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 CUTTING THE CORD TO PRIVATE CORD 
BLOOD BANKING: ENCOURAGING 
COMPENSATION FOR PUBLIC CORD 
BLOOD DONATIONS AFTER FLYNN V. 
HOLDER 
 
SEEMA MOHAPATRA 
 
This Article argues that the Ninth Circuit’s recent 
ruling in Flynn v. Holder, which allowed compensation for 
peripheral blood stem cells (“PBSCs”) obtained via 
apheresis1 under the National Organ Transplant Act 
(“NOTA”), also opens up the possibility for compensation for 
umbilical cord blood (“cord blood”). The holding in Flynn 
applies to cord blood for several reasons. First, Flynn held 
that bone marrow was subject to NOTA’s prohibition on 
compensation because bone marrow was explicitly 
mentioned in the statute. In contrast, no mention of cord 
blood appears in NOTA or its applicable regulations. Also, 
the procedure to utilize cord blood was not in practice at the 
time of NOTA passage and could therefore not have been 
contemplated by Congress. Additionally, similar to PBSCs, 
when Congress revisited NOTA and passed later 
amendments adding fetal organs to the prohibition on 
payment, it chose not to modify the statute to explicitly 
include cord blood. Finally, there is a longstanding view 
that blood should not be covered by NOTA’s prohibitions 
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Sanjay Reddy for their helpful comments on earlier drafts of this Article, and to 
Dean Leticia Diaz and Barry University Dwayne O. Andreas School of Law for 
supporting this research with a Winter Research Grant. 
 1. Apheresis refers to the process whereby the whole blood is removed from a 
donor, the blood is separated into individual components, the specific portion of 
the blood needed is separated and the remaining blood is introduced back into the 
bloodstream of the donor. Melissa Conrad Stöppler, Apheresis, 
MEDICINENET.COM, http://www.medicinenet.com/hemapheresis/article.htm; see 
also infra notes 44–50 and accompanying text. 
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and this should apply equally to cord blood. 
Until recently, bone marrow transplants and PBSC 
transplants were the only two options for individuals 
suffering from diseases that damaged bone marrow, such as 
leukemia and lymphoma. However, advances in technology 
have allowed cord blood transplants to become a viable 
alternative to marrow and PBSC transplants for patients 
who have been unsuccessful in finding a PBSC or bone 
marrow match. This Article contends that rather than 
focusing only on increasing the numbers of bone marrow 
and PBSC donors, it is prudent to focus on increasing cord 
blood donations as a method of overcoming this problem. 
The lack of minority or mixed-race bone marrow, PBSC, and 
cord blood donors in the United States is a significant public 
health problem that has not been addressed adequately. 
Cord blood is taken from the umbilical cord of a 
newborn after the cord has been detached from the baby. 
Cord blood can be used to treat more than seventy diseases. 
Expectant mothers are not well-informed about the option to 
donate cord blood. Often, a pregnant woman’s sole source of 
information about cord blood is from marketing materials 
provided by private cord blood banks. These private banks 
offer to store a baby’s cord blood for a hefty yearly fee, selling 
this service as a sort of life insurance policy that could be 
cashed in should the child get sick in the future. The 
American Academy of Pediatrics and the American College 
of Obstetrics and Gynecology advise against private cord 
blood banking because stored cord blood is of very little 
value to the individual from whom it was retrieved. In 
contrast, cord blood that is donated to a public bank can be 
very useful to individuals requiring a bone marrow 
transplant. Additionally, recipients of cord blood 
transplants are able to withstand an imperfect match 
compared to recipients of bone marrow or PBSC transplants. 
This is significant because it is difficult to find exact 
matches for racial minorities and mixed race individuals. 
Currently, almost 97 percent of cord blood is discarded as 
medical waste. In addition to compensation, this Article also 
suggests other methods of making public cord blood 
donation a more common practice. 
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INTRODUCTION 
 
Devan Tatlow was twenty months old when he was 
diagnosed with a rare form of leukemia.2 The disease had 
initially responded to chemotherapy and Devan went into 
remission.3 Unfortunately in 2010, when he was four years old, 
the disease returned and Devan needed a bone marrow 
transplant.4 Devan’s parents launched a desperate campaign to 
find a suitable bone marrow match for their son.5 A match can 
occur only if a bone marrow donor has a very high genetic 
similarity to a recipient.6 Because Devan is a multiracial 
child—his father is Irish and his mother half Polish and half 
South Asian—it was very difficult to find an appropriate bone 
marrow match.7 Only 3 percent of potential bone marrow 
donors in the National Marrow Donor Program’s8 “Be the 
Match” registry (“NMDP”) of eight million donors are 
multiracial.9 After an extensive international search and 
 
 2. Jonathon LaPook & Phil Hirschkorn, Leukemia Patient—at 4—Highlights 
Marrow Need, CBS NEWS (May 30, 2010, 7:35 AM), http://www.cbsnews.com/ 
2100-18563_162-6531012.html. 
 3. Id. 
 4. Id. 
 5. Jonathon LaPook, M.D., Umbilical Cord Blood: Save It and Save Lives, 
CBS NEWS (June 18, 2010, 1:39 PM), http://www.cbsnews.com/2100-503823_162-
6591788.html. 
 6. Id. 
 7. LaPook & Hirschkorn, supra note 2; see also Tanya Snyder, Boy, 4, 
Desperately Needs Bone Marrow Transplant, WTOP (May, 17, 2010, 10:01 PM), 
http://www.wtop.com/109/1958736/Boy-4-desperately-needs-bone-marrow-
transplant. 
 8. Although still referred to as the National Marrow Donor Program 
(NMDP), 42 U.S.C. §274l-1(2) (2006) replaced the National Bone Marrow Donor 
Registry with the C.W. Bill Young Cell Transplantation Program in an effort to 
increase transplants. 42 U.S.C. §274k (2006). The largest donor registry in the 
United States is the NMDP. Noel Barnard, Throw Me a Bone Marrow Transplant: 
Peripheral Blood Stem Cells and the National Organ Transplant Act, 13 N.C. J. L. 
& TECH. 387, 392 (citing AM. CANCER SOC’Y, STEM CELL TRANSPLANTS 
(PERIPHERAL BLOOD, BONE MARROW, AND CORD BLOOD TRANSPLANTS) 10 (2011)). 
NMDP’s Be The Match Registry (“Registry”) contains 16.5 million donors and 
adds approximately 54,000 donors every month. NAT’L MARROW DONOR PROGRAM 
& BE THE MATCH, KEY MESSAGE, FACTS & FIGURES 1 (2012), available at 
http://marrow.org/workarea/DownloadAsset.aspx?id=1071. There is a dearth of 
minority donors in the Registry. The Registry contains almost seven million 
potential white donors, but only about 685,000 African-American donors. 
Barnard, supra. A white person has a 93 percent chance of finding a donor 
through the NMDP, while Blacks have only a 66 percent of finding a donor. NAT’L 
MARROW DONOR PROGRAM & BE THE MATCH, supra. 
 9. Sandra G. Boodman, Multiracial Patients Struggle to Find Donors for 
Bone Marrow Transplants, WASH. POST (June 1, 2010), http://www. 
washingtonpost.com/wp-dyn/content/article/2010/05/31/AR2010053102481.html. 
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recruitment campaign to attempt to recruit more multiracial 
donors, Devan’s family was still unable to find a bone marrow 
match.10 
A decade ago, the lack of such a match would have meant 
that Devan’s prospects at survival were dim and the story 
would end here. However, in the last several years, cord blood 
transplants are increasingly being used to treat diseases that 
were previously only treated with bone marrow transplants.11 
Thankfully, Devan’s family was able to locate a matching cord 
blood unit, and Devan is a healthy little boy due to a successful 
cord blood transplant.12 
Just as in Devan’s case, cord blood transplants are 
increasingly becoming a viable alternative to bone marrow 
transplants for those individuals who are unable to find a bone 
marrow match.13 Similar to bone marrow, cord blood contains 
blood-forming cells that can be used in transplants for patients 
with leukemia and lymphoma as well as many other life-
threatening diseases.14 This is particularly significant for those 
in minority and mixed-race populations, who are much less 
likely to find a bone marrow or PBSC match using the NMDP 
registry than whites.15 Bone marrow donors need to have an 
even higher genetic similarity to their recipients than cord 
blood and organ donors.16 It is not rare for minorities or mixed-
race individuals in the United States to die while waiting for a 
matching bone marrow donor or stem cell donor.17 Within the 
 
 10. Id. 
 11. Cord Blood is Changing Lives, NAT’L MARROW DONOR PROGRAM, 
http://marrow.org/Get_Involved/Donate_Cord_Blood/Cord_Blood_is_Changing_ 
Lives/Cord_Blood_Is_Changing_Lives_Today.aspx (last visited Nov. 10, 2012). 
 12. Tanya Snyder, Doctors Find Match for Boy in Need of Transplant, WTOP 
(June 18, 2010, 2:14 PM), http://www.wtop.com/?nid=25&sid=1959996. 
 13. Cord Blood is Changing Lives, supra note 11. 
 14. Id. 
 15. Currently, there are only 165,000 umbilical cord blood units on the Be The 
Match Registry. Id. There is still a lack of cord blood units from minority and 
mixed race patients. Id. “Adding more cord blood units from diverse racial and 
ethnic backgrounds to the registry increases the likelihood that all patients will 
find a match.” Id. 
 16. Christopher Shay, Bone Marrow Transplants: When Race Is an Issue, 
TIME MAG. (June 3, 2010), http://www.time.com/time/health/article/ 
0,8599,1993074,00.html. 
 17. Shawn Doherty, Racial Disparities Found Throughout Organ Transplant 
Process, THE CAP TIMES (July 30, 2010, 10:00 AM), http://host.madison.com/ct/ 
news/local/health_med_fit/article_1175c506-9b4a-11df-828c-001cc4c002e0.html. 
Unlike for bone marrow or cord blood, “race is not a direct factor” when seeking an 
organ match. Id. It is possible for a person of one race to receive a kidney from a 
person of another race. Id. However, the “odds are that people of the same ethnic 
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NMDP registry, the vast majority of donors are white.18 
Unfortunately, there is a dearth of donors of other races.19 
Within the NMDP, white recipients find a willing donor 65 
percent of the time, while Latinos find a willing donor only 45 
percent of the time, Asian patients only 40 percent of the time, 
 
or racial background are more likely to have compatible blood and tissue types.” 
Id. For this reason, race still plays an important role in organ donations as 
minorities have a more difficult time than whites in finding matching organ 
donors. See Nicolette Young, Note, Altruism or Commercialism? Evaluating the 
Federal Ban on Compensation for Bone Marrow Donors, 84 S. CAL. L. REV. 1205, 
1212 (2011). For example, in 2010, 108,983 people were on the waiting list for 
various organs, and over 25 percent of these people were African-Americans. April 
A. Robinson, Double Standards and Hypocrisy in the Altruistic Organ 
Procurement Model: Generous Donors But Irrational Negotiators? 32 HAMLINE J. 
PUB. L. & POL’Y 37, 42 (2010). With regard to kidneys, “[w]hile only 13 percent of 
the country’s population, blacks make up 40 percent of those on dialysis.” 
Doherty, supra. Of African-Americans who registered for a kidney transplant 
seven years ago, 39 percent are either still waiting or have died. Id. This number 
is “nearly twice the proportion of white patients.” Id. The median waiting period 
for organs is long and it has increased drastically across the board. Michele 
Goodwin, The Body Market: Race Politics & Private Ordering, 49 ARIZ. L. REV. 
599, 616 (2007). In 2001 and 2002 the median wait for a kidney was 1,284 days for 
whites and 1,842 days for African-Americans. Id. Part of this problem is the 
disparity between races in organ donations in general, as there is a reluctance of 
minorities to become organ donors. Doherty, supra. For example, “in Wisconsin, 
54 percent of drivers have checked the ‘yes’ box for organ donation on their 
driver’s licenses.” Id. However, consent rates for African-Americans in Wisconsin 
are half that. Id. One of the factors that has been an obstacle to recruiting more 
African-American donors is “overcoming a profound distrust of the medical 
system.” Id. The number of Hispanic organ donors also shows a disinclination 
towards donating an organ. Jim Forsyth, Many Hispanics Hesitant About Organ 
Donation, REUTERS (Mar. 28, 2011, 11:23 AM), http://www.reuters.com/ 
article/2011/03/28/us-tranplants-organs-idUSTRE72R46R20110328. This trend 
has been credited by some to religious beliefs. Carmen Radecki Breitkopf,  
Attitudes, Beliefs and Behaviors Surrounding Organ Donation Among Hispanic 
Women, 14 Current Opinion in Organ Transplantation 191(2009), 
http://journals.lww.com/co-transplantation/Fulltext/2009/04000/Attitudes,_beli 
efs_and_behaviors_surrounding_organ.17.aspx.  In Texas in 2010, 31 percent of 
organ donors were Hispanic, while “42 percent of the state’s population is 
[Hispanic].” Jim Forsyth, Many Hispanics Hesitant About Organ Donation, 
REUTERS (Mar. 28, 2011, 11:23 AM), http://www.reuters.com/ 
article/2011/03/28/us-tranplants-organs-idUSTRE72R46R20110328. 
 18. NAT’L MARROW DONOR PROGRAM & BE THE MATCH, supra note 8, at 2. On 
the national registry, only a small percentage of the 8 million volunteer donors 
are people of color. Id. Seventy-three percent are white, 9 percent are Latino, 8 
percent are African-American, 7 percent are Asian/Pacific Islanders, 3 percent are 
multi-racial, and 1 percent are Native American. Laura Landro, Building 
Diversity in Bone-Marrow Registries, WALL ST. J., May 27, 2009, 
http://online.wsj.com/article/SB124338408532856679.html. 
 19. Young, supra note 17, at 1212 (stating that the proportion of minority 
bone marrow donors on the National Bone Marrow registry does not equal their 
population percentage). 
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and African-Americans only 34 percent of the time.20 Finding a 
bone marrow donor for a person of mixed race is “more difficult, 
and often impossible.”21 Cord blood is easier to match than 
bone marrow and requires less genetic similarity.22 Although 
there is still a racial and ethnic component to cord blood, 
increasing cord blood donations will help minorities and mixed 
race individuals who are unable to find a bone marrow or 
PBSC match.23  
This Article proposes that the recent Ninth Circuit Court 
of Appeals (“Ninth Circuit”) decision, Flynn v. Holder,24 which 
held that payments for PBSC obtained via apheresis are 
allowed, would allow payment for cord blood as well. This 
Article argues that compensating umbilical cord blood donors 
could be an effective way to close the gap for minorities and 
mixed-race individuals who are in need of bone marrow 
transplants, without facing any of the potential ethical 
landmines that may arise in compensating bone marrow 
donors. 
Part I of this Article discusses the value of cord blood for 
patients who need bone marrow transplants, particularly 
minority and mixed race patients. Part I also describes the lack 
 
 20. Id. 
 21. Id. A recent example of a mixed race individual that died due to the lack 
of bone marrow donors is Shannon Tavarez. See Bruce Weber, Shannon Tavarez, 
Nala in ‘Lion King,’ Dies at 11, N.Y. TIMES, Nov. 3, 2010, http://www.nytimes. 
com/2010/11/03/theater/03tavarez.html. Tavarez was diagnosed with acute 
myelogenous leukemia, an aggressive blood cancer requiring a bone marrow 
transplant, seven months into her role as Nala on the Broadway show, “The Lion 
King.” Id. Like many mixed race individuals needing bone marrow transplants, 
Shannon, whose father was Latino and mother was black, was unable to find a 
suitable bone marrow match. Juliana Barbassa, Mixed-Race Patients Struggle to 
Find Marrow Donors, PHYSORG.COM (May 27, 2009), available at 
http://www.physorg.com/news162659550.htm.She was able to extend her life, 
however, by finding a match from donated umbilical cord blood and having a cord 
blood transplant. See Bruce Weber, Shannon Tavarez, Nala in ‘Lion King,’ Dies at 
11, N.Y. TIMES, Nov. 3, 2010, http://www.nytimes.com/2010/11/03/theate 
r/03tavarez.html. Unfortunately, the umbilical cord blood transplant was not 
successful and Shannon died in 2010 when she was only eleven years old. Id. 
 22. HLA Matching: Finding the Best Donor or Cord Blood Unit, NAT’L 
MARROW DONOR PROGRAM, http://marrow.org/Patient/Transplant_Process/ 
Search_Process/HLA_Matching__Finding_the_Best_Donor_or_Cord_Blood_Unit.a
spx#hla (last visited Nov. 10, 2012). 
 23. Id. “Human leukocyte antigen (HLA) typing is used to match patients and 
donors for bone marrow transplants or cord blood transplants.” Id. Some racial 
and ethnic groups have HLA types that are less common. Id. Therefore, for both 
bone marrow and cord blood, the best chance of finding a suitable donor is with 
someone of a similar racial or ethnic background. Id. 
 24. 684 F.3d 852, 865 (9th Cir. 2012). 
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of public cord blood donations due in part to the proliferation of 
private cord blood banks. Part II discusses NOTA and the 
reasons for the ban on compensation for certain organs and 
bodily materials under NOTA. Part III examines other 
biological material for which compensation is allowed under 
NOTA—such as blood, sperm, and eggs—and examines the 
historical basis for these distinctions. Part IV discusses the 
Flynn decision and the arguments that both parties put forth 
regarding whether bone marrow and PBSC donors should be 
compensated under NOTA. Part V addresses the criticisms of 
the Flynn decision regarding allowing payment for certain 
types of PBSC extractions. Finally, Part VI argues that under 
Flynn and NOTA, cord blood is a biological material for which 
compensation is or should be allowed. Part VI also proposes 
ways that the compensation system for cord blood could be 
structured to create a robust public cord blood donation system 
in the United States instead of the current system, which is 
dominated by private cord blood banks and reserves donations 
for those who can afford to preserve their own cord blood, 
rather than for those who need it most. This Article concludes 
that utilizing a combination of policies, including compensation 
for cord blood, would increase the number of pregnant women 
who donate their cord blood to a public bank and make a 
significant public health impact by helping minorities and 
mixed-race individuals who need bone marrow and stem cell 
transplants have a greater chance of finding a match. 
 
I. WHY CORD BLOOD TRANSPLANTS ARE IMPORTANT 
 
A. The Science Behind Cord Blood Transplants 
 
The advent of cord blood transplantation as a viable 
alternative to bone marrow transplantation has given hope to 
patients who have been unsuccessful in finding a PBSC or bone 
marrow match. Patients whose bone marrow has been 
destroyed by disease need to replace their damaged bone 
marrow cells.25 There are three ways to replace bone marrow in 
a diseased individual: bone marrow, PBSC transplants, or cord 
blood transplants.26 Each of these methods is explained in turn 
 
 25. THE AM. CANCER SOC’Y, STEM CELL TRANSPLANT (PERIPHERAL BLOOD, 
BONE MARROW, AND CORD BLOOD TRANSPLANTS) 1 (Nov. 1, 2012), 
http://www.cancer.org/acs/groups/cid/documents/webcontent/003215-pdf.pdf. 
 26. Id. Although commonly referred to as bone marrow transplants, the most 
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below. 
 
1. Bone Marrow and PBSC Transplants 
 
To understand the arguments presented in this Article, it 
is important to understand the science behind bone marrow 
transplants and PBSC transplants. Bone marrow refers to the 
spongy tissue, located inside the hollow part of certain bones,27 
which forms red and white blood cells and platelets.28 It 
contains hematopoietic stem cells that can develop into any 
type of blood cell.29 When a person suffers from a disease that 
destroys his or her bone marrow, such as leukemia or 
lymphoma, he or she often needs a bone marrow transplant.30 
Marrow cells and PBSCs carry a marker called the human 
leukocyte antigen (“HLA”).31 HLA proteins, located in a 
person’s cells, determine that person’s tissue “type.”32 HLA 
markers allow one’s body to recognize foreign cells.33 This 
immune response can be deadly when a person receives a 
necessary bone marrow or cord blood transplant.34 In order to 
reduce this adverse immune response, transplant patients are 
matched with donors having a tissue type that is as similar as 
possible to that of the recipient.35 HLA tissue types are 
 
common transplants to replace bone marrow are peripheral stem cell transplants. 
Id. at 6. In these transplants, peripheral stem cells are extracted from a donor via 
apheresis. Id. at 11. In rare circumstances, actual bone marrow is transplanted. 
Id. at 8. Bone marrow is retrieved via the aspiration technique. Fact Sheet, Bone 
Marrow Transplantation and Peripheral Blood Stem Cell Transplantation, NAT’L 
CANCER INST. (Sept. 24, 2010), http://www.cancer.gov/cancertopics/factsheet/Th 
erapy/bone-marrow-transplant. 
 27. THE LEUKEMIA & LYMPHOMA SOC’Y, BLOOD AND MARROW STEM CELL 
TRANSPLANTATION 38 (2010), http://www.lls.org/content/nationalcontent/resourcec 
enter/freeeducationmaterials/treatments/pdf/bloodmarrowstemcelltransplantation
.pdf. 
 28. BE THE MATCH, YOUR INTRODUCTION TO MARROW AND CORD BLOOD 
TRANSPLANT 7 (2011), http://marrow.org/Patient/Support_and_Resources/ 
Resource_Library/Learn_resources/An_Introduction_to_Marrow_and_Cord_Blood
_Transplant_(PDF).aspx. 
 29. Fact Sheet, Bone Marrow Transplantation and Peripheral Blood Stem Cell 
Transplantation, supra note 26. 
 30. Id. 
 31. THE LEUKEMIA & LYMPHOMA SOC’Y, supra note 27, at 43. 
 32. Id. 
 33. BE THE MATCH, supra note 28, at 8. 
 34. HLA Matching: Finding the Best Donor or Cord Blood Unit, supra note 22. 
 35. Id. at 8. Cord blood is now being used as an alternative to peripheral stem 
cell or bone marrow transplants. AM. ACAD. OF PEDIATRICS, Cord Blood Banking 
for Potential Future Transplantation, 119 PEDIATRICS 165, 165 (2007), available 
at http://pediatrics.aappublications.org/content/119/1/165.full.pdf+html. In comp-
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genetically inherited, which is why the most successful 
matches are usually from one’s own family members36—
siblings have a 25 percent chance of having the same HLA 
tissue type.37 Therefore, the instances of HLA identity between 
unrelated patients and donors are relatively few in number. 
Patients who are from ethnic minority groups or are of mixed-
race backgrounds have an even poorer chance of finding a full 
HLA match with an unrelated adult donor due to genetic 
heterogeneity and the fact that most marrow donors are 
white.38 
Once a matching donor is identified, bone marrow can be 
transplanted in one of two ways: aspiration or stem cell 
apheresis.39 Bone marrow transplants used to be performed 
only through aspiration.40 Aspiration is a surgical procedure 
where a special hollow needle is inserted into the pelvic bone to 
extract the marrow.41 The donor’s body typically replenishes 
the lost bone marrow within four to six weeks.42 
PBSC apheresis was developed three decades ago and is 
now the most common method of bone marrow 
transplantation.43 The bloodstream contains hematopoietic 
stem cells that migrate from the bone marrow.44 These cells are 
collected in a manner similar to that used for collecting blood 
donations, but after collection the donor’s blood is run through 
 
arison to bone marrow, the risk of graft-versus-host disease is diminished 
compared with similarly mismatched stem cells from the peripheral blood or bone 
marrow of a related or unrelated donor. Id. Cord blood is also a useful option 
when a patient’s cells do not match an adult donor closely enough. Id. at 166. 
“Biologically, a greater degree of human leukocyte antigen mismatch is tolerated 
by the recipient and the incidence of acute graft-versus-host reaction is decreased 
when umbilical cord blood is used.” THE AM. COLL. OF OBSTETRICIANS & 
GYNECOLOGISTS, ACOG COMMITTEE OPINION NO. 399, UMBILICAL CORD BLOOD 
BANKING 1 (Feb. 2008), available at http://www.acog.org/~/media/Committee% 
20Opinions/Committee%20on%20Obstetric%20Practice/co399.pdf?dmc=1&ts=201
20722T1521237632. Studies show that cord blood does not need to match as 
closely as bone marrow. Id. 
 36. BE THE MATCH, supra note 28, at 8. 
 37. See Barnard, supra note 8. 
 38. AM. ACAD. OF PEDIATRICS, supra note 35, at 166. The plaintiffs in Flynn 
sought to compensate bone marrow and peripheral stem cell donors to increase 
the number of donors for these individuals. Flynn v. Holder, 684 F.3d 852, 855 
(9th Cir. 2012). 
 39. Barnard, supra note 8, at 393 (citing Fact Sheet, Bone Marrow 
Transplantation and Peripheral Blood Stem Cell Transplantation, supra note 26.). 
 40. Barnard, supra note 8, at 393. 
 41. Id. 
 42. Id. 
 43. Id. at 394. 
 44. Id. 
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an apheresis machine which isolates the PBSCs.45 To ensure a 
sufficient number of these cells for transplantation, donors are 
given drugs for several days prior to donation.46 The collection 
process itself takes a few hours and does not require 
hospitalization.47 
 
2. Cord Blood Transplants 
 
Cord blood is now commonly used as an alternative to bone 
marrow transplants or PBSC transplants and can treat more 
than seventy different diseases.48 Cord blood is taken from the 
umbilical cord and placenta of a newborn baby after the 
delivery of the child.49 Like PBSCs, cord blood contains 
hematopoietic stem cells that have the potential to be life-
saving for people with some cancers, immune deficiencies, 
inherited disorders, and metabolic disorders.50 
In addition to being both extremely therapeutic and easy to 
collect, cord blood has wide usage because recipients of cord 
blood transplants are able to withstand a less perfect type 
match than recipients of bone marrow transplants.51 This is 
especially significant for racial minorities and mixed race 
individuals for whom it is very difficult to find exact bone 
marrow matches.52 Just like bone marrow cells, cord blood cells 
carry an HLA marker.53 Because cord blood transplants 
require less exact matching, even with cord blood 
transplantation being in its relative infancy compared with 
marrow transplants, racial minorities and mixed race 
individuals have had better luck finding cord blood matches 
than bone marrow matches.54 
 
 45. Id. at 395. 
 46. Id. 
 47. Id. 
 48. Jeannette Moninger, The Cord Blood Controversy: Insurance—or 
Reassurance?, PARENTS MAG., http://www.parents.com/pregnancy/my-baby/cord-
blood-banking/the-cord-blood-controversy/ (last visited Nov. 10, 2012). 
 49. THE AM. CANCER SOC’Y, supra note 25. 
 50. THE AM. ACAD. OF PEDIATRICS, supra note 35. 
 51. Id. at 165–66. Cord blood transplant recipients can withstand human 
leukocyte antigen mismatch and suffer much less graft-versus-host reaction than 
bone marrow transplant recipients. Id. at 166. Additionally, in comparison to bone 
marrow, the risk of graft-versus-host disease is diminished compared with 
similarly mismatched stem cells from the peripheral blood or bone marrow of a 
related or unrelated donor. Id. 
 52. Cord Blood is Changing Lives, supra note 11. 
 53. THE LEUKEMIA & LYMPHOMA SOC’Y, supra note 27, at 43. 
 54. Reasons to Bank Cord Blood, PARENT’S GUIDE TO CORD BLOOD 
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Cord blood transplants are also preferred over bone 
marrow or PBSC transplants when a patient does not have a 
lot of time due to the progression of his or her disease.55 Cord 
blood transplants occur over a three-week period as opposed to 
the six weeks it takes if there is a PBSC or bone marrow 
match.56 
Cord blood contains a low number of stem cells acquired 
per unit compared with other sources of stem cells.57 For this 
reason, cord blood transplants were often not used in large 
adults.58 However, technology has progressed and now 
combined units of umbilical cord blood are used, which greatly 
increases the potential for cord blood transplants in a wider 
variety of patients.59 
 
B. The Process of Cord Blood Donation 
 
In order to donate cord blood to most public banks, the 
expectant mother must be pregnant with a single baby, be at 
least eighteen years of age, and have no reason to expect 
delivery earlier than thirty-five weeks gestation.60 The 
procedure to collect cord blood from the delivered placenta does 
not interfere with labor and delivery,61 and there are no risks 
 
FOUNDATION, http://parentsguidecordblood.org/reasons.php (last modified May 
30, 2012). Bone marrow should be “matched at least for the HLA-A, -B, -C and -
DRB1 alleles. Since there are usually two alleles for each, in a perfect match, the 
donor will have the same eight alleles as the patient, an 8/8 match. A perfect 
match is most likely to occur among family members.” Cord Blood Q & A: Why Do 
We Need to Have Cord Blood Donated to Public Cord Blood Banks?, NAT’L CORD 
BLOOD PROGRAM, http://www.nationalcordbloodprogram.org/qa/why_do_we_need_ 
it.html (last visited Nov. 10, 2012). In contrast, successful matches for cord blood 
have been 5/6 or 4/6 matches for HLA-A, -B and -DRB1 antigens. Id. Thus, 
patients who do not have a bone marrow match may have an easier time finding a 
cord blood match for transplant. 
 55. Cord Blood Stem Cells Help Meet Minority Marrow Needs, STEM CELL 
INST., (Mar. 1, 2010), http://www.cellmedicine.com/cord-blood-stem-cells-help-
meet-minority-marrow-needs/. 
 56. Id. 
 57. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1. 
 58. Id. 
 59. Id. 
 60. The Arizona Public Cord Blood Banking Program—Frequently Asked 
Questions, ARIZ. DEP’T OF HEALTH SERVS., http://azdhs.gov/biomedical/aztransnet/ 
documents/ArizonaPublicCordBloodBankingProgram.pdf (last visited Feb. 20, 
2013). 
 61. Eligibility Guidelines for Collecting Cord Blood Stem Cells, CORD BLOOD 
BANKING (Aug. 10, 2011), http://www.cordbloodbanking.com/tag/collecting-cord-
blood/. 
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to the mother or child when donating.62 After a baby is born, 
the umbilical cord is clamped.63 To extract cord blood, a needle 
with a bag attached is inserted into the portion of the cord that 
is no longer attached to the baby.64 After this, the bag is sealed, 
and the placenta is then delivered.65 Cord blood cannot be used 
in certain limited circumstances, such as when the blood 
carries infection, in cases of premature birth, birth of multiple 
babies, or emergencies during labor and delivery.66 
After the cord blood is collected, the blood is placed in a 
tamper-proof, temperature-monitored container for 
transportation via land or air to the cord blood bank.67 At the 
cord blood bank, the personnel then check the integrity of the 
cord blood donation and the accompanying paperwork.68 The 
blood is then weighed and tested for extreme temperature 
changes since it was harvested.69 The cord blood bank next 
separates the stem cells from the cord blood, tests the stem 
cells for potency, infectious diseases, and viability, identifies 
the genetic characteristics of the cells and then freezes and 
stores the unit of cells.70 The information is then put into the 
database for future matching.71 
 
C. The Need for More Cord Blood 
 
There is a sheer lack of donated cord blood units. The 
NMDP’s “Be the Match Registry” is the largest registry of 
potential marrow donors and donated cord blood units in the 
world.72 The Registry contains the information of almost 10.5 
million potential donors, but only has a mere 185,000 available 
 
 62. Cord Blood Donation, NAT’L CORD BLOOD PROGRAM, www.nationalco 
rdbloodprogram.org/donation/prospective_donor_faq.html (last visited Nov. 11, 
2012). 
 63. Eligibility Guidelines for Collecting Cord Blood Stem Cells, supra note 61. 
 64. Id. 
 65. Cord Blood Banking Frequently Asked Questions, THE AM. COLL. OF 
OBSTETRICIANS AND GYNECOLOGISTS (Aug. 2011), http://www.acog.org/~/media 
/For%20Patients/faq172.pdf?dmc=1&ts=20120625T1219143933. 
 66. Id. 
 67. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-12-23, NATIONAL CORD BLOOD 
INVENTORY: PRACTICES FOR INCREASING AVAILABILITY FOR TRANSPLANTS AND 
RELATED CHALLENGES 11 (Oct. 2011). 
 68. Id. 
 69. Id. 
 70. Id. 
 71. Id. 
 72. NAT’L MARROW DONOR PROGRAM & BE THE MATCH, supra note 8, at 1. 
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cord blood units.73 Given how valuable cord blood is, this 
number is much too low, the numbers and percentages 
specifically of mixed race and minority donors and cord blood 
units are very low. The vast majority of cord blood units—over 
one hundred thousand—are from whites.74 There are only 
about thirteen thousand black cord blood units, three hundred 
Native American cord blood units, eighteen thousand Asian 
cord blood units, thirty-four thousand Latino cord blood units, 
150 Native Hawaiian cord blood units, and less than seventeen 
thousand mixed-race cord blood units.75 
The United States Congress, recognizing the need for 
genetically diverse and high quality units of cord blood, passed 
the Stem Cell Therapeutic and Research Act of 2005.76 The 
goal of the Act was to bank an additional 150,000 new cord 
blood units.77 Additionally, the Secretary of the Department of 
Health and Human Services (“HHS”) established the National 
Cord Blood Inventory (“NCBI”), a program that supports public 
cord blood banking for use in transplants.78 One of the main 
goals of the NCBI is to increase the genetic diversity of cord 
 
 73. Id. at 3. 
 74. Id. at 2. 
 75. Id. 
 76. U.S. GOV’T ACCOUNTABILITY OFFICE, supra note 67, at 1; see also Stem 
Cell Therapeutic and Research Act of 2005, Pub. L. No. 109–129, 119 Stat. 2550 
(codified as amended in 42 U.S.C. § 274(k)–(m)). 
 77. U.S. GOV’T ACCOUNTABILITY OFFICE, supra note 67, at 1. The Stem Cell 
Act authorized the appropriation of $60 million in federal funds through 2010 in 
order to make more units of cord blood available for transplantation. Id. 
 78. Id. at 2. The Food and Drug Administration (“FDA”) also regulates cord 
blood banks. The FDA requires that cord blood banks register with the FDA and 
comply with current manufacturing, tissue handling, and storage practices and 
screen potential donors for certain diseases. Id. at 14. Additionally, now, all cord 
blood units must be approved by the FDA. Id. at 15. The Stem Cell Act created an 
Advisory Council to assist and advise the Secretary of Health and Human 
Services and Administrator of Health Resources and Services on how to perform 
the activities related to managing the National Cord Blood Inventory. Id. at 14. 
The Advisory Council consists of twenty-five members such as cord blood and 
bone marrow donor centers, recipients of transplants, transplant centers, and 
banks that partake in workgroups to develop and present recommendations on 
how the National Cord Blood Inventory should operate. Id. The GAO report 
contained recommendations from banks that adding more staff at collection sites 
during more hours of the day or more days of the week, providing recognition or 
feedback to motivate medical staff about cord blood collections, and lowering the 
age of consent for donating cord blood could all increase collections. Id. at 16. The 
GAO report acknowledges that competition from private banks and limited 
resources make increasing collections at existing sites more difficult. Id. Another 
suggestion in the GAO report to increase cord blood collections was to expand the 
number of collections sites. Id. at 17. These efforts could be focused on hospitals 
with a high number of minority births. Id. 
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blood units available to help ethnic and racial groups find 
matches for transplants.79 In 2010, the Stem Cell Therapeutic 
and Research Reauthorization Act of 2010 authorized more 
funding to increase and support the growth of cord blood 
donations to public banks.80 
The Government Accountability Office recently submitted 
a Report to Congressional Committees on the NCBI.81 In the 
National Cord Blood Inventory, 1 percent of the cord blood 
units are from American Indian/Alaskan Natives donors, 10 
percent from Asian donors, 10 percent from black/African 
American donors, 13 percent from Latino donors, and 59 
percent from white donors.82 Clearly, there remains a 
substantial lack of minority cord blood donors in the United 
States.83 More than 40 percent of minority patients suffering 
from a bone marrow disease requiring transplantation use cord 
blood transplants.84 If the number of cord blood donations from 
 
 79. Id. at 2. In order to meet these goals, the Health Resources and Services 
Administration entered into thirteen contracts with cord blood banks. Id. By May 
31, 2011, the banks had been reimbursed $45.7 million for over 41,000 units of 
cord blood. Id. Under the practices used to increase racial and ethnically diverse 
cord blood donations, a new pilot program for remote collection of cord blood may 
help increase the opportunities to donors in locations where access to public banks 
is difficult. Id. at 11–12. According to the GAO report, the remote collections could 
not be added to the National Cord Blood Inventory because of FDA licensure 
requirements. Id. at 12. If the remote collection can be adjusted to meet the 
requirements of NCBI and FDA, this program could increase the number of cord 
units from sites around the country that do not have access or opportunity to do so 
now, which would likely increase the number of cord blood units from racial and 
ethnically diverse groups. Another practice used to increase racial and ethnically 
diverse cord blood donations is the awarding of contracts to banks through a 
competitive request-for-proposal process. Id. The Stem Cell Act required that the 
contract be for ten years and that no funds would be obligated under the contracts 
three years after they were entered into. Id. The contract also requires that the 
cord blood be available for transplant indefinitely or for as long as it is deemed 
viable by Health and Human Services. Id. As part of the competitive process, each 
bank puts forward a number of units based on ethnic and racial groups that the 
bank will provide to the National Cord Blood Inventory each year. Id. By doing so, 
Health Resources and Services Administration use these competitive measures to 
increase the diverse minority units available in the Inventory for transplant. Id. 
at 12–13. The Health Resources and Services Administration (HRSA) now pays 
banks higher rates for minority group units compared to the units collected from 
non-Latino Whites. Id. at 13. 
 80. Id. at 2. 
 81. Id. 
 82. Id. at 7. 
 83. See id. 
 84. Sara Farris, Mothers Give the Gift of Life Twice with Cord Blood 
Donation, UNIV. OF TEX. MD ANDERSON CANCER CTR. (Sept. 19, 2012, 11:08 AM), 
http://www2.mdanderson.org/cancerwise/2012/09/mothers-give-the-gift-of-life-
twice-with-cord-blood-donation.html. 
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racially and ethnically diverse donors is increased, more 
matches can be made for minorities, increasing the likelihood 
that those patients will find a match that could save their 
lives.85 As discussed later in this Article, the NCBI’s goals 
could be achieved if a system of compensation for cord blood 
donors is instituted.86 
 
D. The Proliferation of Private Cord Blood Banks and the 
Lack of Public Cord Blood Banks: A Public Health 
Problem 
 
Although the federal government has been advocating the 
establishment of larger and more widespread umbilical cord 
blood banks, there currently is not an easily accessible public 
cord blood banking option in most areas of the United States.87 
Cord blood donations are largely the domain of private cord 
banks, and there are currently only twenty-nine public cord 
blood banks in the United States.88 Researchers have found 
that “the abundance of private cord blood banking options 
coupled with the lack of a public cord blood bank alternative in 
most areas of the United States prevents the public health 
benefits [of cord blood donation], such as improved access to 
stem cell transplant for underrepresented minorities, from 
being realized.”89 
The current scheme of cord blood donation in the United 
States is fraught with serious problems. First, pregnant women 
 
 85. See Cord Blood Stem Cells Help Meet Minority Marrow Needs, supra note 
55. 
 86. See infra Part VI.B. 
 87. Anjali J. Kaimal et al., Cost-effectiveness of Private Umbilical Cord Blood 
Banking, 114(4) OBSTETRICS & GYNECOLOGY 848, 853 (2009). 
 88. Find a USA Public Bank, PARENT’S GUIDE TO CORD BLOOD FOUND., 
http://parentsguidecordblood.org/public_usa.php (last modified Oct. 25, 2012). Not 
all hospitals work with public banks. Id. For a list of hospitals that participate 
and work with cord blood banks, see Participating Hospitals, NAT’L MARROW 
DONOR PROGRAM, http://marrow.org/Get_Involved/Donate_Cord_Blood/How_to_ 
Donate/Participating_Hospitals.aspx (last visited Feb. 8, 2013). “The first public 
bank was established at the New York Blood Center in 1991 and other public 
banks have since been established in various regions of the country.” THE AM. 
COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1. 
 89. Kaimal et al., supra note 87. Even developing countries, such as Mexico, 
are beginning to establish public cord blood banks. See Micheal Boo, Public Cord 
Blood Banking May Play an Important Role in the Emergence of Unrelated 
Transplant in Developing Countries, 48 TRANSFUSION 207, 207 (Feb. 2008), 
http://www.imss.gob.mx/salud/BancoSangre/Documents/RolBanco.pdf. 
Unfortunately, even in these countries, private cord blood banks are preventing a 
robust public cord blood banking system. See Kaimal et al., supra note 87, at 848. 
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and prospective fathers are often uneducated about cord blood 
donation in general.90 Often, public banking is not even 
mentioned to expectant families prior to the birth of their 
babies. Although twenty-seven states have passed legislation91 
to encourage the discussion of the cord blood banking option, 
this appears to benefit the private cord banking industry 
instead of encouraging cord blood donation. Although some 
states follow the Institute of Medicine guidelines, which 
require discussion of all cord blood options, other states simply 
require education in general with no specifications.92 
Additionally, the majority of public and private hospitals 
in the United States do not have a direct connection to a public 
bank.93 There are only a limited number of hospitals in the 
United States that participate in the NMDP’s cord blood 
banking program.94 In addition to these sites, the National 
Cord Blood Program also has a limited number of collection 
sites, and these are mostly in New York.95 If a woman is not 
delivering in any of the NMDP participating hospitals, she has 
the option of donating to one of only four public banks that 
accept mail-in donations.96 In contrast, representatives from 
private cord blood banks establish friendly relationships and 
leave promotional materials at obstetricians’ offices.97 
 
 90. MARY HAWS ET AL., DEP’T OF MED. LAB. SCI., WEBER STATE UNIV., 
KNOWLEDGE AND PERCEPTIONS OF CORD BLOOD DONATION AMONG PREGNANT 
WOMEN 1–2, http://www.weber.edu/WSUImages/DCHPResearch/mls_2011_12_ 
projects/GRP4_OUR.pdf (last visited March 12, 2013). 
 91. 27 States Have Cord Blood Education Laws, PARENT’S GUIDE TO CORD 
BLOOD FOUND., http://parentsguidecordblood.org/news/12/ (last modified Mar. 28, 
2012). These states include: Arizona, Arkansas, California, Colorado, Connecticut, 
Florida, Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan, 
Missouri, New Jersey, New Mexico, New York, North Carolina, North Dakota, 
Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, 
Washington, and Wisconsin. Id. 
 92. Id. 
 93. Public and Private Cord Blood Banks, SAVE THE CORD FOUND., 
http://savethecordfoundation.org/banking_list.php (last visited Mar. 8, 2013). 
 94. Participating Hospitals, supra note 88. 
 95. Cord Blood Donation, supra note 62. The NCBP’s collection sites are New 
York-Presbyterian Hospital’s Cornell Weill Medical Center; Brooklyn Hospital 
Center; Montefiore Medical Center/Albert Einstein College of Medicine of Yeshiva 
University Weiler Hospital; Mount Sinai Medical Center; North Shore University 
Hospital in Manhasset; Long Island Jewish (LIJ) Medical Center; Inova-Fairfax 
Hospital; and MacDonald Hospital for Women. Id. 
 96. Donating at Other Hospitals, NAT’L MARROW DONOR PROGRAM, 
http://marrow.org/Get_Involved/Donate_Cord_Blood/How_to_Donate/Donating_at
_Other_Hospitals.aspx (last visited Feb. 8, 2013). 
 97. See Sophie Ramsey, Docs Weigh in on Private Cord-Blood Banking, 
CONSUMER NEWS (Mar 19, 2009), http://news.consumerreports.org/health/2009/ 
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E. Private Cord Blood Banks: The Hype and the Reality 
 
Despite the greater abundance of information on private 
cord blood banking over public, the realities of the process do 
not match the hype. Private banking is not cost-effective, will 
not likely be useful to those who bank the blood, and 
professional organizations are opposed to it. 
 
1. Cord Blood Banking is Not Cost Effective 
 
The private cord banking industry markets cord blood 
storage for future use as a sort of insurance policy98—a private 
reserve of stem cells that parents can draw upon in the event 
that their child develops a bone marrow disease. 
An illustrative example of private cord blood bank 
advertising to pregnant women is the Cord Blood Registry’s 
(“CBR”) website.99 CBR’s slogan is “Healthy Futures Born 
Here.”100 The website gives a one-sided narrative of private 
banking and gives inspiring real life stories of how private 
banking has saved lives.101 There is not one mention of public 
banking on the website. CBR private storage for cord blood and 
tissue costs a total of $2,895 for the first year, which is made 
up of a one-time cord blood and tissue collection/processing fee 
of $2,790, a one-time shipping fee of $170, and an annual 
storage fee of $260. However, the reality is that private cord 
blood banking does not assure a healthy future for a baby. 
A recent study by University of California researchers 
found that privately storing umbilical cord blood was not cost-
effective unless the family had a long history of blood 
disorders.102 This study found that the odds of privately stored 
umbilical cord blood being used for the family in the next 
twenty years was very small and not worth the expense of 
storing the cord blood privately for most families.103 
Researchers estimate that the chance that an individual 
 
03/private-umbilical-cord-blood-banking.html. 
 98. Moninger, supra note 48. 
 99. Cord Blood Banking at its Best, CORD BLOOD REGISTRY, http://www. 
cordblood.com/en/best-cord-blood-bank (last visited Feb. 8, 2013). 
 100. Id. 
 101. See Our Clients, Their Stories, CORD BLOOD REGISTRY, http://www.cord 
blood.com/en/benefits-cord-blood/our-clients-their-stories (last visited Feb. 9, 
2013). 
 102. Kaimal et al., supra note 87, at 848. 
 103. Id. at 853. 
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may actually use his or her own cord blood in lieu of receiving 
transplantation from another donor is one in five thousand per 
individual.104 The cost of collection and storage usually comes 
with a hefty price tag. Private cord blood banking is not cost-
effective because it costs an additional $1,374,246 per life-year 
gained.105 Additionally, a survey by the American Society for 
Blood and Marrow Transplantation found that only ninety-nine 
of the approximately 460,000 cord blood units banked in 
private cord blood banks were confirmed as being shipped for 
use in treatment.106 
 
2. Privately Banked Blood Will Likely Never be 
Useful to Those Who Banked It 
 
As noted above, the cost-effectiveness of privately banking 
cord blood is reduced by the low likelihood that the blood will 
actually be useful to those who banked it. Parents who bank 
their baby’s cord blood have a less than 0.04 percent chance of 
ever being able to use that blood to help their child and an only 
slightly higher chance for family members.107 
Because of the way cord blood banking is marketed, many 
parents who choose to invest in the significant cost of private 
banking do so because they believe that if their child develops a 
disease, this cord blood will be useful in curing their child’s 
disease.108 However, if that child develops a disease such as 
leukemia, using their own cord blood will most likely not be an 
option as the genetic predisposition to the disease is already in 
the cord blood.109 The stored cord blood may only be useful for 
other siblings.110 Even members of the American Congress of 
Obstetricians and Gynecologist’s (“ACOG”) own ethics 
committee have stated that “‘there’s no reason for parents to 
take on this additional financial burden when there’s little 
chance of a child ever using his own cord blood.’”111 Parents 
 
 104. Private Cord Blood Banking: The Basics, BABY CTR., http://www. 
babycenter.com/0_private-cord-blood-banking-is-it-for-you_1369773.bc (last up-
dated June 2012). 
 105. Kaimal et al., supra note 87, at 848. 
 106. Id. 
 107. Id. 
 108. Id. 
 109. Cord Blood Banking Pros and Cons, M.A.Z.E. CORD BLOOD LABS., 
http://www.mazecordblood.com/private-vs-public.htm (last visited Feb. 8, 2013); 
see also Moninger, supra note 48. 
 110. Cord Blood Banking Pros and Cons, supra note 109. 
 111. Moninger, supra note 48. 
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have recently filed lawsuits after realizing the futility of cord 
blood banking when their child has been diagnosed with an 
illness caused by a genetic problem.112 
 
3. Professional Organizations Oppose Private Cord 
Blood Banking for Most Individuals 
 
Professional organizations discourage the use of private 
cord blood banking. The American Academy of Pediatrics 
discourages private cord blood storage and encourages public 
cord blood donation.113 In February 2008, ACOG released a 
policy about umbilical cord blood banking.114 It encourages 
obstetricians to provide a patient who requests information on 
umbilical cord blood banking with balanced and accurate 
information regarding the advantages and disadvantages of 
public versus private banking.115 It advises physicians to 
educate pregnant women about the “remote chance of an 
autologous unit of umbilical cord blood being used for a child or 
a family member (approximately 1 in 2,700 individuals).”116 
ACOG further advises that cord blood collection not alter 
routine practice for the timing of umbilical cord clamping.117 
Finally, ACOG advises that “physicians . . . who recruit 
pregnant women and their families for for-profit umbilical cord 
blood banking should disclose any financial interests or other 
potential conflicts of interest.”118 
The American Association of Pediatrics (“AAP”) is 
similarly negative about the benefits of private cord blood 
 
 112. See, e.g., id. For example, the Dones chose to privately bank their son 
Anthony’s cord blood. Id. When Anthony was diagnosed with osteopetrosis, a 
potentially fatal disorder that affects bone formation, at four months of age, the 
Dones were shocked to discover the cord blood they had stored could not be used 
to save Anthony. Id. The cord blood could not be used for transplant because the 
cells had the same genetic defect that caused Anthony’s illness. Id. The Dones 
have filed a lawsuit against the private cord blood bank claiming false advertising 
and consumer fraud. Id. This is based on their claims that they were told in 
printed materials given to them by the private cord bank that storing the cord 
blood was akin to a life insurance policy that could save Anthony’s life should he 
need it in the future. Id. The bank never mentioned the possibility that the cells 
that were stored would contain the debilitating disease as well. Id. 
 113. See AMERICAN ACAD. OF PEDIATRICS, supra note 35, at 167. 
 114. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1. 
 115. Id. at 2. The policy notes that the benefits of “long-term storage of 
autologous umbilical cord blood [have] been questioned.” Id. 
 116. Id. 
 117. Id. 
 118. Id. 
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banking.119 AAP warns, “Cord blood-banking recruitment 
practices should be developed with an awareness of the 
possible emotional vulnerability of pregnant women and their 
families and friends. Efforts should be made to minimize the 
effect of this vulnerability on cord blood-banking decisions.”120 
If cord blood transplants are to remain a viable alternative 
to bone marrow and PBSC transplants, collection and banking 
procedures will need to be addressed. Although NOTA, which is 
discussed in the following sections, specifically addresses organ 
transfer and donation, it is silent as to cord blood, leaving 
questions about collection and banking open for debate, 
especially after the Flynn v. Holder decision. 
 
II. THE NATIONAL ORGAN TRANSPLANT ACT OF 1984 AND THE 
POLICY REASONS BEHIND THE BAN ON COMPENSATION FOR 
ORGANS 
 
Under NOTA,121 which was enacted in 1984, it is unlawful 
for any person to knowingly transfer any human organ for 
valuable consideration for use in human transplantation if the 
transfer affects interstate commerce.122 NOTA defines “human 
organ” as any human kidney, liver, heart, lung, pancreas, bone 
marrow, cornea, eye, bone, and skin or any subpart thereof or 
any other human organ specified by the Secretary of Health 
and Human Services by regulation.123 When the statute speaks 
of “valuable consideration”124 it does not include reasonable 
 
 119. See AM. ACAD. OF PEDIATRICS, supra note 35, at 166. 
 120. Id. at 167–68. 
 121. 42 U.S.C. § 274e (2007). 
 122. Id. § 274e(a). Some countries do allow compensation for organs. 
Compensation for living organ donors is legal in Iran. Lisa M. Derco, Note, 
America’s Organ Donation Crisis: How Current Legislation Must be Shaped by 
Successes Abroad, 27 J. CONTEMP. HEALTH L. POL’Y 154, 163–64 (2010). This is 
done through a state regulated system. Id. at 163. Through this system, donors 
receive $1,200 as well as health insurance from the government for their 
donation. Id. at 164. Additionally, donors receive compensation from the donee. 
Id. If the donee cannot afford to pay this compensation then “several charities 
have been established to provide compensation to the donor.” Id. This practice has 
led to Iran being the only country in the world that does not have a shortage of 
donated organs. Id. at 163; see also Alex Tabarrok, The Meat Market, WALL ST. J., 
Jan. 8, 2010, http://online.wsj.com/article/SB1000142405274870348100457464623 
3272990474.html. 
 123. 42 U.S.C. § 274e(c)(1) (2007). 
 124. Although live organ donations are not compensated in most countries, 
some countries allow for the medical expenses that were incurred during the 
transplant to be reimbursed. See Derco, supra note 122; see also Amnon Meranda, 
Knesset Approves Organ Donation Law, YNETNEWS.COM (March 25, 2008, 2:00 
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payments that are associated with the procedure itself.125 
Additionally, payments that are meant to reimburse the donor 
for travel expenses and lost wages are allowable.126 
The legislative history of NOTA states that “human body 
parts should not be viewed as commodities.”127 However, it 
does not specifically state the reasons for this view. In Flynn v. 
Holder, the Ninth Circuit presented possible policy reasons for 
this stance.128 First, the court supposed that Congress might 
have been concerned that poor patients could be induced to sell 
their organs creating medical risks or pain for poor donors.129 
Second, the court theorized that patients needful of transplants 
might be threatened by matching donors to give them 
exorbitant amounts of money or face death.130 The Ninth 
Circuit also suggested that Congress might have thought that 
the practice of extracting organs by fraud or force could be 
stimulated.131 Finally, the court presented the notion that 
Congress may have worried that this practice could “degrade 
the quality of the organ supply, by inducing potential donors to 
lie about their medical histories in order to make their organs 
 
PM), http://www.ynetnews.com/articles/0,7340,L-3523461,00.html; see also Benny 
Moshe & Hana Levi Julian, Organ Donor Compensation Bill Passes Knesset 
Committee, ISRAELI NAT’L NEWS (Jan. 7, 2010, 4:28 PM), 
http://www.israelnationalnews.com/News/News.aspx/135415. In the United 
States, under 42 U.S.C. § 274e, “valuable consideration” for the selling or 
transplanting of organs is prohibited; however, reasonable payments that 
reimburse the donor for the medical expenses of the transplant are permitted. See 
42 U.S.C. § 274e(a), (c)(2) (2007) (noting that these costs are not prohibited and by 
inference would be permitted). 
 125. 42 U.S.C. § 274e(c)(2). It is important to note that this law does not apply 
to human organ paired donation. Id. § 274e(a). Human organ paired donation is 
described as when one donor (donor 1) wants to donate a human organ to a 
particular patient (patient 1) but the donor is biologically incompatible as a donor 
for the patient. Id. § 274e(c)(4)(A). There is also a second donor (donor 2) who 
wants to donate a human organ to a different particular patient (patient 2) but is 
also biologically incompatible as a donor for the patient. Id. § 274e(c)(4)(B). If 
donor 1 is biologically compatible as a donor to patient 2 and donor 2 is a 
biologically compatible donor for patient 1, the statute does not apply. Id. § 
274e(a). 
 126. 42 U.S.C. § 274e(a), (c)(2). 
 127. S. REP. NO. 98-382, at 17 (1984), reprinted in 1984 U.S.C.C.A.N. 3975, 
3982.  
 128. Flynn v. Holder, 684 F.3d 852, 860 (9th Cir. 2012). 
 129. Id.; see also Jennifer M. Smith, “Dirty Pretty Things” and the Law: Curing 
The Organ Shortage & Health Care Crises in America, 12 CHAP. L. REV. 361, 368–
69 (2008) (arguing that the supply of living donors will largely come from the poor 
segment of society—a segment that is often exploited). 
 130. Flynn, 684 F.3d at 860. 
 131. Id. 
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marketable.”132 
In addition to these policy arguments, the Ninth Circuit 
also presented possible philosophical reasons for the 
prohibition on compensation of organ donations133—namely, 
that commerce regarding organs “is generally seen as 
revolting.”134 The Ninth Circuit attributed this to cultural 
taboos.135 With regard to the argument that certain groups will 
be exploited if compensation for organ donors were allowed, 
some argue that “there is a lack of empirical evidence to 
conclusively establish that offering economic incentives will 
promote organ donations. Yet, there is clear evidence 
demonstrating [that] economic incentives for donating parts of 
the human body will lead to exploitation of underprivileged 
groups.”136 However, the argument that this compensation 
scheme will lead to exploitation of underprivileged groups is 
harder to make in the bone marrow context. Supporters of the 
ban on compensation ostensibly seek to protect ethnic minority 
groups from exploitation; however, these are the very groups 
that are the most disadvantaged by the status quo lack of 
donors.137 
It has further been suggested that if donors were 
compensated, this new marketplace would drive out altruistic 
donors, thereby decreasing both the supply and quality of 
donated organs.138 However, financially motivated and 
 
 132. Id. 
 133. Id. at 861. Some countries, like Israel, have created ways for donors to be 
compensated. Meranda, supra note 124. In Israel, a recently enacted law allows 
for a person who has made living organ donations of a kidney or part of a liver to 
attain the status of “chronic patient.” Id.; see also Moshe & Julian, supra note 124. 
This means that the donor does not “have to pay the self-participation fee for any 
medical service resulting from the donation.” Meranda, supra note 124. 
Furthermore, the donor is compensated approximately $5,100 from the State. Id. 
This money is viewed as a “ ‘safety net’ against financial and health damages that 
may be caused by the organ donation.” Moshe & Julian, supra note 124. Singapore 
now compensates organ donors as well. Cody Corley, Money as a Motivator: The 
Cure to Our Nation’s Organ Shortage, 11 HOUS. J. HEALTH L. & POL’Y 93, 112 
(2010). The country plans to compensate “as much as US $36,000 to individuals 
that are willing to donate their organs.” Id. 
 134. Flynn, 684 F.3d at 861. 
 135. Id. 
 136. Jennifer L. Hurley, Cashing In On the Transplant List: An Argument 
Against Offering Valuable Compensation for the Donation of Organs, 4 J. HIGH 
TECH. L. 117, 132–33 (2004) (arguing that in the past, blood and plasma donors 
have been unemployed, indigent, and substance-addicted). 
 137. See Young, supra note 17, at 1228–29. 
 138. Id. at 1228. The demand for bone marrow in a market that outlaws 
compensation for donors has led to unorthodox methods of procuring donations. In 
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altruistic donors can co-exist.139 Moreover, when looking at the 
level of blood donations that existed before and after 
compensation was allowed, the total amount of donations 
increased.140 Arguably, this shows that even if the number of 
altruistic organ donations dropped, the total number of 
donations could still rise.141 
Another argument that has been presented is that if an 
open market were created for organs, then poor people would 
 
2010, the Caitlin Raymond International Registry and UMASS Memorial Health 
Ventures Inc. hired models to recruit potential bone marrow donors. Denise 
Lavoie, Bone Marrow Donor Recruiting Cases Settled, CBS BOSTON (Feb. 2, 2012, 
8:37 PM), http://boston.cbslocal.com/2012/02/02/bone-marrow-donor-recruiting-
cases-settled/#.Tyv3jt6ferk.email. Wearing high heels and short skirts, these 
fashion models attempted to “recruit potential registrants during donor drives at 
malls, festivals and sporting ventures.” Id. Afterwards, both entities were accused 
of “improperly waiv[ing] copayments and deductible amounts for the testing of 
potential donors, g[iving] away free T-shirts and h[olding] free raffles for big-
screen televisions and golf clubs.” Id. These activities led to claims of improper 
marketing practices for which these entities paid $770,000 to the states of 
Massachusetts and New Hampshire. Id. Although certainly questionable, these 
practices were effective. Id. Additionally, Caitlin Raymond International Registry 
and UMass Memorial Health Ventures Inc. were charged with inflating the rates 
of individual donor tests. Id. While these tests only cost $50 to administer, the 
price charged by UMass Memorial ranged from network rates of several hundred 
dollars to up to more than $4,000. Id. “[D]onor tests performed by UMass 
Memorial increased significantly, from about 7,000 in 2008 to more than 40,000 in 
2010.” Id. Remarking on the issue, Douglas Brown, the senior vice president and 
general counsel of UMass Memorial Healthcare Inc., said that it was regrettable 
that certain “practices may have undermined the public perception of the life-
saving importance of donor recruitment.” Id. However, Brown also stated that 
these practices did not cause anyone any harm. Id. Furthermore, Brown also 
pointed out that “48 patients received transplants from donors in the past year as 
a result of the registry’s past recruitment efforts.” Id. 
 139. Young, supra note 17, at 1228 (citing DAVID PRICE, LEGAL AND ETHICAL 
ASPECTS OF ORGAN TRANSPLANTATION 397 (2000)). In fact, some, like 
constitutional scholar Eugene Volokh, argue that allowing payment for organs 
may be a type of medical self-defense. Allan J. Jacobs, Is State Power to Protect 
Health Compatible with Substantive Due Process Rights?, 20 ANNALS HEALTH L. 
113, 119 (2011). Volokh argues that the “common law right of self-defense and 
constitutional guarantees of substantive due process should” prevent the 
government from regulating “therapeutic modalities in some clinical 
circumstances.” Id. Additionally, Volokh has also argued that the Supreme Court 
has already recognized medical self-defense in the context of abortion. Eugene 
Volokh, Medical Self-Defense, Prohibited Experimental Therapies, and Payment 
for Organs, 120 HARV. L. REV. 1813, 1824 (2007). This concept has been described 
as an apparent right to defend oneself through the use of medical care. Id.  
Although the Supreme Court has only recognized the medical self-defense right in 
abortion cases, Volokh has argued that it is logical to extend this right when 
people need to medically defend themselves through an organ transplant. Id. at 
1826. 
 140. See Young, supra note 17, at 1235 n.197. 
 141. Id. 
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be denied access to organs.142 This argument has been attacked 
with the assertion that “the use of money to acquire organs 
from donors and the use of money to allocate organs to waiting 
recipients” are two different things.143 Therefore, “financial 
incentives can be incorporated readily within the current 
system without any alteration in the manner through which 
transplantable organs are distributed to patients. The only 
difference would be that more organs would become available 
for distribution.”144 
 
III. PAYMENT ALLOWED FOR BLOOD, SPERM, AND EGGS 
UNDER NOTA: WHY? 
 
Beginning in the 1910s and lasting until the 1970s “a 
significant percentage of the United States’ blood supply was 
derived from paid human donors.”145 The first documented 
blood transfusion took place in 1818.146 However, the results of 
early transfusions were normally unsuccessful.147 It was not 
until the discovery of multiple blood groups in the early 
twentieth century that transfusions became more reliable, 
opening the door to blood donations and blood banks.148 The 
revolutionary Blood Transfusion Betterment Association 
(“BTBA”) was founded in 1929 in New York149 to provide blood 
to New York and the surrounding areas.150 The donors were 
compensated per hundred cubic centimeters provided.151 
Technological advances and increased knowledge of blood 
and blood storage led to the practice of civilians donating blood 
 
 142. See Corley, supra note 133, at 105–06 (arguing against this assertion). 
 143. Id. 
 144. Id. at 106 (citing T. Randolph Beard & David L. Kaserman, On the Ethics 
of Paying Organ Donors: An Economics Perspective, 55 DEPAUL L. REV. 827, 831 
(2006)). 
 145. Julia D. Mahoney, The Market for Human Tissue, 86 VA. L. REV. 163, 171 
(2000). 
 146. Id. at 171 n.23. 
 147. Id. 
 148. See generally id. 
 149. The Charles R. Drew Papers: Becoming “the Father of the Blood Bank,” 
1938–1941, NAT’L LIBR. OF MED., http://profiles.nlm.nih.gov/ps/retrieve/ 
Narrative/BG/p-nid/338 (last visited Nov. 14, 2012) [hereinafter Charles R. Drew 
Papers]. 
 150. Blood Transfusion Betterment Association, 6 BULL. OF THE N.Y. ACAD. OF 
MED. 682, 682 (1930), available at http://www.ncbi.nlm.nih.gov/pmc/articles/ 
PMC2096130/. 
 151. Id. at 684. 
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and supplying it to forward medical installations.152 This 
program was first used in Spain during the Spanish Civil 
War,153 and a similar program was instituted by the United 
States at the onset of World War II.154 A relief program called 
“Blood for Britain” collected blood in American hospitals and 
shipped it to England.155 This program was also intended to 
gather the information that would be necessary to implement 
“a nationwide blood banking program if the U.S. entered the 
war.”156 In addition to the Blood for Britain campaign, in 1940, 
the Red Cross began looking for civilian groups to provide blood 
to ensure a supply would be available to the armed forces if 
there were ever a national emergency.157 
Throughout World War II the number of donors depended 
“largely upon the ebb and flow of battle.”158 During times of 
lower military activity, it was difficult for the program to 
obtain an adequate number of donors.159 Although the donors 
did not receive any payment for their service, they were given 
an emblem and a certificate signifying their donation.160 
After World War II, human sperm also began to be seen as 
a marketable commodity.161 Much like blood donors, donors of 
human sperm were compensated for their donations.162 
“[A]lthough artificial insemination and blood transfusions did 
not gain immediate public acceptance,” the objections that were 
raised by the public centered on the practices themselves, 
rather than the compensation of donors.163 However, these 
sentiments did not prevail, and criticism of donors of bodily 
fluids centered on the commodification of these donations.164 
 
 152. See Brigadier General Douglas B. Kendrick, Blood Program in World War 
II, U.S. ARMY MED. DEP’T 11, available at http://history.amedd.army.mil/ 
booksdocs/wwii/blood/DEFAULT.htm (last visited Feb. 12, 2013). 
 153. Id. 
 154. Charles R. Drew Papers, supra note 149. 
 155. Id. 
 156. Id. 
 157. Kendrick, supra note 152, at 101. 
 158. Id. at 119–20. 
 159. Id. at 119. 
 160. Id. at 148. Another non-monetary incentive to donate blood was the 
concept of “blood-time,” where a number of states created “blood-time” programs 
under which inmates that donated blood were able to serve reduced sentences. See 
Jamila Jefferson-Jones, The Exchange of Inmate Organs for Liberty: Diminishing 
the “Yuck Factor” in the Bioethics Repugnance Debate, 16 J. GENDER RACE & 
JUST. 105, 132 (2013). 
 161. Mahoney, supra note 145, at 171. 
 162. Id. 
 163. Id. 
 164. See Kenneth Baum, Golden Eggs: Towards the Rational Regulation of 
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In fact, many of the arguments that are currently used 
against the commodification of organs were used against the 
commodification of donating blood, sperm, and eggs. In the case 
of blood, when commercial blood banks first began paying 
people for their blood, there were many opponents who claimed 
that this commodification would “repress altruism, increase the 
risks of unethical medical practice, and exploit the poor to 
provide for the rich.”165 
Some argue that paying people for their blood would result 
in a decrease in the number of charitable donations.166 In the 
book The Gift Relationship, Roger Titmuss argued that by 
paying people for their blood, “the altruistic motivations that 
lead individuals to donate their blood for free” were 
undermined.167 This, he hypothesized, would lead to 
“[i]ndividuals who would have otherwise donated their blood 
for free [being] persuaded by self-interest to ask for the 
compensation they now thought they deserved.”168 Titmuss 
claimed that “offering material rewards for blood donations 
might backfire and lower donations.”169 However, a 2011 study 
involving nearly one hundred thousand individuals and 
seventy-two blood drives concluded that “providing material 
rewards led to a large and significant increase in the 
propensity to donate.”170 Furthermore, this effect increased 
when the incentive for donating increased.171  
 
Oocyte Donation, 2001 BYU L. REV. 107, 136 (2001). 
 165. Corley, supra note 133, at 111 (quoting Gail L. Daubert, Politics, Policies, 
and Problems with Organ Transplantation: Government Regulation Needed to 
Ration Organs Equitably, 50 ADMIN. L. REV. 459, 481 (1998)). 
 166. See Baum, supra note 164, at 136–37. 
 167. Id. at 137. 
 168. Id. 
 169. Nicola Lacetera et al., Rewarding Altruism? A Natural Field Experiment 
26 (Nat’l Bureau of Econ. Research, Working Paper No. 17636, 2011) (discussing 
Titmuss’s arguments on payment for blood donations). But see Baum, supra note 
164, at 137 (“Whether or not such a shift would lead to an overall increase or 
decrease in donations is arguable and likely depends on the amount of 
compensation provided. But Titmuss was concerned with more than just 
decreasing numbers of blood donors. He was also concerned with the broader 
social implications that such a shift would endorse.”). 
 170. Lacetera et al., supra note 169, at 2, 26. 
 171. Id. It has been suggested that this trend also exists with egg donors. Egg 
donations are accompanied with a degree of risk not found in blood donations. 
Russell Korobkin, Buying and Selling Human Tissues for Stem Cell Research, 49 
ARZ. L. REV. 45, 60 (2007). “The procedure is painful, is accompanied by the risk of 
bleeding and infection, and carries a small but non-trivial risk of substantial 
medical complications.” Id. As such, “there are likely to be far fewer altruistic egg 
donors.” Id. 
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Additionally, some felt that by offering financial 
incentives, the quality of donated blood would suffer.172 This 
idea was predicated on the belief that this lure of money would 
attract “poor individuals harboring infectious diseases [who] 
would have reason not to disclose their medical history.”173 It 
was thought that if these individuals donated blood, the 
donated blood “could harm or even kill its recipient.”174 
However, with modern technology, blood banks have 
“extremely accurate screening techniques for the major blood-
borne infectious diseases.”175 Similarly, egg donors are 
“carefully screened through histories, physicals, . . . and genetic 
testing.”176 Regardless of this initial reluctance to embrace the 
commodification of blood donors, “commercial blood banks are 
now widely accepted as commonplace and viewed as a 
necessary tool for . . . hospitals.”177 
 
IV. FLYNN V. HOLDER: OPENING UP THE POSSIBILITY FOR 
COMPENSATION FOR CERTAIN TYPES OF BODILY MATERIAL 
 
The Flynn v. Holder178 decision is significant because it is 
the first time the Ninth Circuit has interpreted NOTA and 
examined whether a particular bodily material falls within its 
purview. In Flynn, the District Court dismissed the plaintiffs’ 
claims that NOTA’s ban on payment for bone marrow and 
PBSCs was unconstitutional.179 However, upon appeal, the 
Ninth Circuit stated that payment for PBSCs did not violate 
NOTA.180 The Flynn court held that NOTA was constitutional, 
making this decision through its interpretation of the statute 
itself.181 Although some scholars have read Flynn as a narrow 
decision that will not lead to creation of markets beyond PBSCs 
obtained through apheresis,182 this Article contends that Flynn 
opens up the possibility that additional bodily material, such as 
 
 172. Baum, supra note 164, at 140. 
 173. Id. 
 174. Id. 
 175. Id. 
 176. Id. 
 177. Corley, supra note 133, at 111. 
 178. 684 F.3d 852 (9th Cir. 2012). 
 179. Id. at 855. 
 180. Id. at 865. 
 181. I. Glenn Cohen, Selling Bone Marrow—Flynn v. Holder, 366 NEW ENG. J. 
MED. 296, 296 (2012), available at http://www.nejm.org/doi/pdf/10.1056/ 
NEJMp1114288. 
 182. See, e.g., id. 
2013] CUTTING THE CORD 961 
cord blood, may be exempted from NOTA. This section 
discusses the key points that were raised in Flynn. In Part VI, 
Flynn’s reasoning is applied to cord blood. The Article 
concludes that, based on the reasoning in Flynn, cord blood 
payment would be allowed under NOTA. 
 
A. Plaintiffs’ Arguments 
 
Until recently, NOTA had been interpreted as forbidding 
compensation for organs, including bone marrow.183 The Flynn 
v. Holder case involved several individuals who challenged this 
prohibition on compensation for bone marrow donations as 
unconstitutional.184 The plaintiffs included parents of children 
who would benefit from bone marrow donations; a physician 
who provided bone marrow transplants; a parent of a mixed-
race child who struggled to find matching donors; an African 
American man who suffered from leukemia; and, most 
importantly, MoreMarrowDonors.org (“MMD”), a California 
nonprofit corporation that sought to operate a program that 
would incentivize bone marrow donations.185 
NOTA makes it a crime to compensate the donation of a 
“human organ.”186 The plaintiffs in Flynn v. Holder argued that 
NOTA should not be applied to bone marrow, as bone marrow 
donors suffer no permanent harm, experience “no significant 
risk, and [the body] quickly regenerates what is donated.”187 
This claim centered on the argument that the application of 
NOTA to bone marrow violated the Equal Protection Clause of 
the Constitution.188 The plaintiffs argued that because bone 
marrow donations can be accomplished through apheresis, 
“there is no rational basis for allowing compensation for blood, 
sperm, and egg donations while disallowing compensation for 
bone marrow donations.”189 Specifically, the plaintiffs sought 
declaratory and injunctive relief so that a pilot program called 
“MoreMarrowDonors.org” could begin offering financial 
 
 183. See 42 U.S.C. § 274e (2007). 
 184. Flynn, 684 F.3d at 855. 
 185. Id. at 855–56. All of the plaintiffs were connected to MMD in some 
manner. See id. at 858. 
 186. See 42 U.S.C. § 274e. 
 187. Flynn, 684 F.3d at 858. 
 188. Id. 
 189. Id. “The Equal Protection Clause . . . requires the state to articulate a 
rational basis for distinctions that it makes in the law.” Cohen, supra note 181, at 
296. 
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incentives to minority and mixed-race donors of bone 
marrow.190 MMD sought to make bone marrow donation more 
attractive by providing compensation to donors.191 MMD was 
hoping to offer $3,000 awards in the form of scholarships, 
housing allowances, or charitable donations to potential 
donors.192 
The plaintiffs further argued that all bone marrow donors, 
regardless of the method of transplant, should be allowed to 
receive compensation.193 They contended that donors should 
receive compensation if they donated bone marrow or PBSCs, 
regardless of the method used to retrieve the material.194 
In attempt to show a violation of the Equal Protection 
Clause in the application of NOTA to apheresis bone marrow 
donation, the plaintiffs claimed: (1) there is no logical 
connection to any rational basis; or (2) the distinction between 
blood donations and apheresis bone marrow donation “produces 
effects so irrational as to be unconstitutional.”195 
The plaintiffs maintained that there was no logical 
connection to the argument that Congress may have felt that it 
is morally and ethically wrong to sell body parts.196 This is 
because there is no rational basis for the arbitrary distinction 
that it is “perfectly legal to provide scholarships to donors of 
mature blood cells, but makes it a major federal crime to 
 
 190. Flynn, 684 F.3d at 858. Such an act would be “considered a federal crime 
under NOTA.” 9th Circuit Lifts Ban on Selling Bone Marrow: Flynn v. Holder, 19 
No. 8 WESTLAW J. HEALTH L. 8, at 10 (Dec. 29, 2011). 
 191. Flynn, 684 F.3d at 858. 
 192. Id. 
 193. Id. at 859. 
 194. Id. The plaintiffs also argued in their brief that even though the rational 
basis test is deferential to the government there are three circumstances in which 
the Supreme Court has held that a statutory classification lacks a rational basis 
and therefore violates equal protection. Brief of Appellants at 25, Flynn v. Holder, 
684 F.3d 852 (9th Cir. 2012) (No. 10-55643). First, when there is “[n]o logical 
connection between a statutory classification and any hypothetical rational basis,” 
there is no rational basis. Id. at 26 (citing Zobel v. Williams, 457 U.S. 55, 61–62 
(1982)). Secondly, when the effects of the statutory classification “are so 
manifestly irrational that no rational legislator could have intended them” the 
legislation fails the rational basis test. Id. at 28 (citing Allegheny Pittsburg Coal 
Co. v. Cnty. Comm’n, 488 U.S. 336 (1989)). Finally, the plaintiffs argued that 
“[t]he Supreme Court also rejects asserted rational bases that are motivated by 
illegitimate interests such as raw animus toward a disfavored group.” Id. at 29 
(citing City of Cleburne v. Cleburne Living Ctr., 473 U.S. 432 (1985)). 
 195. Id. at 32. The plaintiffs then argued that the possible bases “that the 
district court cited in support of NOTA’s facial validity do not support NOTA as 
applied to Appellants’ pilot program for the strategic compensation of marrow-cell 
donors.” Id. (emphasis in original). 
 196. Id. at 32–33. 
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provide scholarships to donors of immature blood cells.”197 
They further maintained that there was no logical 
connection to the argument that Congress could have been 
concerned that individuals, particularly the poor, will be 
coerced by financial pressure into selling their organs.198 To 
advance this argument, the plaintiffs argued that there is no 
fear of this financial pressure forcing people to donate bone 
marrow since bone marrow is a renewable resource.199 
Therefore, donors do not lose anything and are not in the same 
position to be harmed as they would be if they were donating a 
kidney.200 
Finally, the plaintiffs reasoned that the court should not 
ignore the change in circumstances from when NOTA was 
originally written.201 Essentially, the court should take into 
account the fact that Congress could not have been referring to 
apheresis when NOTA was written as the procedure did not 
exist at that time.202 The plaintiffs urged that the Ninth 
Circuit take this change in circumstances into account.203 
 
B. Defendant’s Response 
 
The Attorney General, as defendant, argued simply “that 
the statute plainly classifie[d] ‘bone marrow’ as an organ for 
which compensation is prohibited.”204 The defendant also 
 
 197. Id. at 33; see also Cancer Patients Win Bone Marrow Legal Fight Against 
U.S. Attorney General, INST. FOR JUSTICE (Dec. 1, 2011), http://www.ij.org/bone-
marrow-release-12-1-2011-2. 
 198. Brief of Appellants, supra note 194, at 33–34. 
 199. Id. at 34. Apheresis only impacts the donor’s blood and is replaceable. Id. 
 200. Id. The plaintiffs went on to argue that there is no logical connection to 
the concern that the rich will be at a substantial advantage for purchasing organs 
because the donations the plaintiffs are planning on facilitating are shielded from 
market-like transactions. Id. at 34–35. In addition to these and other arguments, 
the plaintiffs also contended that their equal protection claim can be bolstered 
because NOTA as applied to them creates effects so irrational as to be 
unconstitutional. Id. at 32. One of these arguments is directed at the District 
Court’s argument that Congress could have been concerned “[t]hat [a]llowing 
[f]inancial [i]ncentives [w]ould [c]reate [a] [p]owerful [i]ncentive [f]or [a] 
[p]otential [d]onor [t]o [p]rovide [a]n [i]naccurate [m]edical [h]istory.” Id. at 37. In 
response to this argument, the plaintiffs argued that if this were to happen, the 
recipients of the marrow cells would have the possibility of an infection. Id. at 38. 
However, if the recipient does not receive any bone marrow cells, the outcome is 
much worse: death. Id. 
 201. Id. at 40–43. 
 202. Id. 
 203. Id. 
 204. Flynn v. Holder, 684 F.3d 852, 858 (9th Cir. 2012). 
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argued that there is a rational basis for distinguishing between 
blood donations and blood stem cell apheresis donations.205 The 
grounds for this argument were that (1) it is harder to find 
matches for bone marrow transplants there will be a greater 
chance of exploitative market forces to take hold, and (2) bone 
marrow transplants have increased health risks over blood 
donations.206 
The Attorney General stated in his reply brief that there is 
no merit to the plaintiffs’ argument that Congress could not 
rationally exclude blood from the scope of NOTA without also 
excluding bone marrow.207 In addition, the Attorney General 
argued that the apheresis method is more involved than 
donating blood.208 
 
C. The Ninth Circuit’s Decision 
 
Ultimately, the Ninth Circuit held for the plaintiffs, 
finding that NOTA did not cover stem cell extraction by 
apheresis and thus compensation was allowed.209 
The court first struck down the plaintiffs’ challenge of the 
constitutionality of the compensation ban on bone marrow via 
the aspiration method.210 The court reasoned that because bone 
marrow is specifically listed as a “human organ” in NOTA, the 
ban applies to it.211 
 
 205. Id. at 859. 
 206. Id. However, the government did not take this argument from assertions 
made in the complaint. Id. Instead, the government took this argument from a 
patient handout called “Now That You Are a Match,” which was published by the 
National Marrow Donor Program. Id. The complaint stated that there was no 
significant risk. Id. The Ninth Circuit held that because this case was dismissed 
on a 12(b)(6) motion, the complaint controls. Id. 
 207. Brief for the Appellee at 15, Flynn v. Holder, 684 F.3d 852 (9th Cir. 2012) 
(No. 10-55643). This is because “‘mere underinclusiveness is not fatal to the 
validity of a law’ under the Fifth Amendment’s guarantee of equal protection.” Id. 
(quoting Atonio v. Wards Cove Packing Co., 10 F.3d 1485, 1495 (9th Cir. 1993) 
(quoting Nixon v. Adm’r of Gen. Services, 433 U.S. 425, 471 n.33 (1977))). 
 208. Id. at 17–18. This is because five days of injections are needed before the 
procedure and “a not insignificant portion of donors require the insertion of a 
central venous line to donate using apheresis, which has its own risks and 
requires a local anesthesia.” Id. Therefore, “Congress violated no constitutional 
restraint by declining to treat bone narrow [sic] donations in the same manner as 
blood donations.” Id. at 20. Finally, the Attorney General argued that Congress 
revisited the statute in 2007, long after the apheresis procedure began to be used 
and that Congress neglected to change the provision. Id. at 19. 
 209. Flynn, 684 F.3d at 865. 
 210. Id. at 859. 
 211. Id. at 859–60. The Ninth Circuit found it irrelevant for this point that 
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The court then addressed the plaintiffs’ “no rational basis” 
argument under the Equal Protection Clause by delineating 
between two classes of rational basis at issue: (1) policy 
concerns and (2) philosophical concerns.212 The Ninth Circuit 
held that the policy concerns were obvious as Congress could 
have had a legitimate concern to protect poor people from being 
induced to sell their organs.213 The court also stated that 
Congress could have had philosophical concerns for prohibiting 
the compensation of organ donors214—namely, people have an 
“instinctive revulsion” at the concept of the removal of flesh 
from a human being for use by another and particularly the 
“commodification” of such conduct.215 
The court further noted that Congress need only show a 
rational basis, not a persuasive basis for their distinction, and 
Congress had done so.216 Therefore, “the prohibition on 
compensation for bone marrow donations by the aspiration 
method [did] not violate the Equal Protection Clause.”217 
The Ninth Circuit additionally stated that there was no 
need to answer any constitutional question relating to the 
apheresis method.218 The court found that Congress did not 
intend to address the method as NOTA contained no express 
prohibition against it, considering that the method did not even 
exist when the statute was passed.219 
The court then examined the text of NOTA to determine 
possible implications about extraction of stem cells by the 
apheresis method.220 The statute prohibits compensation not 
 
Congress viewed certain types of regenerable tissue as falling outside the 
statutory definition of “human organ.” Id. 
 212. Id. at 860. 
 213. Id. The Ninth Circuit noted “that although blood can legally be sold, 
certain differences between blood and bone marrow justify the view of Congress 
that providing financial incentives would reduce altruistic donation and 
undermine voluntary donation.” Cohen, supra note 181, 297. 
 214. Flynn, 684 F.3d at 861. 
 215. Id. 
 216. Id. at 861–62. 
 217. Id. at 862. 
 218. Id. 
 219. Id. 
 220. Id. The Ninth Circuit did not consider whether the compensation of 
donations procured through the apheresis method violated the Equal Protection 
Clause of the Constitution. Had they chosen to decide this issue on those grounds, 
the Ninth Circuit would need to have decided whether allowing the compensation 
for blood donations but not for apheresis donations was rationally related to a 
legitimate government purpose. Even though the Ninth Circuit did not decide the 
case on these grounds, both the plaintiffs and the Attorney General argued 
extensively about whether the NOTA ban on bone marrow donations via 
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only for donation of an organ but also any subpart thereof.221 
The Ninth Circuit rejected the Attorney General’s argument 
that hematopoietic stem cells (which are located in the veins) 
should be treated as “bone marrow,” reasoning that once these 
stem cells are in the bloodstream, they are a “subpart” of the 
blood, not the bone marrow.222 The Ninth Circuit therefore 
concluded that the PBSC apheresis method of bone marrow 
transplantation is not the transfer of an organ or a subpart 
thereof.223 Accordingly, they held that NOTA does not 
criminalize the compensation of the donor when this method is 
used.224 
The Obama administration petitioned the Ninth Circuit for 
a rehearing, arguing that the Ninth Circuit ignored the intent 
of Congress to shield all organ sales from “market forces.”225 In 
 
apheresis violated the Equal Protection Clause in their respective briefs. See Brief 
of Appellants, supra note 194, at 12; Brief for the Appellee, supra note 207, at 11. 
In attempting to argue this position, the plaintiffs contended in their brief to the 
Ninth Circuit that NOTA as applied to them is unconstitutional. Brief of 
Appellants, supra note 194, at 14. The district court dismissed the plaintiffs’ equal 
protection claim based on the conclusion that rational basis review permits only 
facial challenges of law, rather than as-applied challenges. Id. at 15. The plaintiffs 
argued that this was in error as both the Ninth Circuit and the Supreme Court 
regularly hear as-applied challenges in the rational-basis context. Id. at 15–16. 
The Ninth Circuit apparently did not disagree as they heard the case while 
making essentially no mention of as-applied challenges in the opinion. 
 221. 42 U.S.C. § 274e (2007). 
 222. Flynn, 684 F.3d at 863. 
 223. Id. at 865. 
 224. Id. It has been said that the Ninth Circuit’s decision is “both a win and a 
loss for advocates of organ markets.” See Cohen, supra note 181, at 297. The 
decision is a win given that “patients can now buy and sell peripheral-blood stem 
cells derived through apheresis.” Id. However, the win was achieved through the 
Ninth Circuit’s interpretation of NOTA. Id. Congress could always change the 
statute, as the Ninth Circuit did not make its ruling based on the plaintiff’s Equal 
Protection Clause argument. Id. Because of the narrowness in this holding, 
“[n]othing in the Ninth Circuit decision foreshadows the creation of markets in 
any other types of organs.” Id. 
 225. Carol J. Williams, Court Asked to Reconsider Ruling On Bone Marrow 
Compensation, L.A. TIMES (Jan. 18, 2012, 4:45 PM), http://latimesblogs. 
latimes.com/nationnow/2012/01/bone-marrow-compensation.html; see also 
Appellee’s Petition for Rehearing & Rehearing En Banc at 10, Flynn v. Holder, 
684 F.3d 852 (9th Cir. 2012). Additionally, the appeal stated that the panel erred 
when it created a distinction between donations of cells from fatty tissue and 
donations of cells from peripheral blood. Appellee’s Petition for Rehearing & 
Rehearing En Banc, supra, at 2. The Attorney General argued that because 
Congress made no distinction, the panel erred in creating one. Id. at 8–9. The 
Attorney General further argued that this error undermines the scheme that 
Congress created. Id. at 12. Furthermore, the petition stated that even the 
plaintiffs did not claim that the statute is limited to only bone marrow cells 
obtained from fatty tissue. Id. at 8. The petition argued that the plaintiffs’ claim 
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March 2012, the Ninth Circuit denied the government’s 
petition for rehearing and rehearing en banc.226 In that denial, 
the Ninth Circuit rejected the government’s argument that 
because Congress defined “bone marrow” in another statute to 
include cells found in peripheral blood, “bone marrow” should 
be given the same meaning in NOTA.227 Because the Attorney 
General did not petition the Supreme Court to review Flynn, 
the Ninth Circuit’s holding will stand.228 
 
D. The Aftermath 
 
Although advocates of a market-based system for bone 
marrow, organ, or tissue donation were hopeful that Flynn 
would open the door to such markets, the decision was more 
limited in its holding than those advocates had hoped.229 
Although patients can now both buy and sell peripheral blood 
stem cells that were derived through apheresis, the Ninth 
Circuit came to this conclusion through its interpretation of 
NOTA, while still upholding the statute as a whole.230 Because 
Congress could always change the statute, Flynn would have 
had a more far-reaching impact had the Ninth Circuit struck 
down the statute or a portion thereof based on the plaintiffs’ 
 
was based on equal protection issues and centered on the argument that 
“Congress should have limited the scope of the Transplant Act and that it was 
irrational not to do so.” Id. at 8. The government argued that the Ninth Circuit 
panel took it upon themselves to evaluate medical policy and medical science and 
their interpretation is “directly at odds with Congress’s own evaluation.” Id. at 9. 
The petition then stated that “Congress addressed scientific developments in 
transplant methods in the 2005 Amendments [to the Transplant Act] and defined 
‘bone marrow’ to include ‘the cells found in adult bone marrow and peripheral 
blood.’ ” Id. The petition stated that this definition covers the process of apheresis. 
Id. at 9. 
 226. Flynn v. Holder, 665 F.3d 1048 (9th Cir. 2011), amended and superseded 
on denial of rehearing by 684 F.3d 852 (9th Cir. 2012). 
 227. Flynn v. Holder, 684 F.3d at 854. 
 228. Nicholas J. Diamond, Is It Time to Reconsider the National Organ 
Transplant Act?, SCI. PROGRESS (July 16, 2012), http://scienceprogress. 
org/2012/07/is-it-time-to-reconsider-the-national-organ-transplant-act/. The Ninth 
Circuit is bound by the Flynn decision. The Ninth Circuit is comprised of the 
states of Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, Oregon, 
and Washington and the Guam territory. Map of the Ninth Circuit, U.S. COURTS 
FOR THE NINTH CIRCUIT, http://www.ca9.uscourts.gov/content/view.php?pk_ 
id=0000000135 (last visited Mar. 15, 2013). It is by far the largest Circuit in the 
United States. U.S. COURTS FOR THE NINTH CIRCUIT, http://www3.ce9.uscourts. 
gov (last visited Mar. 15, 2013). 
 229. Cohen, supra note 181, 296. 
 230. Id. at 297. 
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equal protection argument.231 Although some scholars argue 
that “[n]othing in the Ninth Circuit decision foreshadows the 
creation of markets in any other types of organs,”232 Part V of 
this Article explores how the Ninth Circuit’s discussion of bone 
marrow obtained through apheresis could also be applied to 
cord blood. Flynn could reasonably be read as allowing 
payment for cord blood, which could have a potentially great 
impact on public health. 
 
V. CRITICISMS OF FUTURE IMPLICATIONS AFTER THE FLYNN 
DECISION 
 
Much of the criticism of the Flynn decision mirrors the 
arguments made by the Attorney General regarding the policy 
behind NOTA’s ban on compensation for organs. That is, 
opponents of any market-based system worry about the 
commodification and coercion that could occur if individuals 
who possessed matching bone marrow types were allowed to 
name their price for their much-needed bone marrow.233 
However, since Flynn was decided, a new concern has 
arisen about allowing compensation for bone marrow in the 
United States. This concern is what effect such payment would 
have on the international community of bone marrow donors 
and registries.234 After the Flynn v. Holder ruling, the nine 
states bound by the decision no longer conform to international 
donor standards that do not accept bodily material that has 
been paid for.235 This is significant because more than half of 
the bone marrow transplants in 2011 made possible by NMDP 
 
 231. Id. 
 232. Id. 
 233. See discussion supra Part II. 
 234. Michael Boo, The Dangers of Repealing Bone Marrow Compensation 
Restrictions, U.S. NEWS & WORLD REPORT (Apr. 19, 2012), http://www.usnews. 
com/opinion/articles/2012/04/19/the-dangers-of-repealing-bone-marrow-
compensation-restrictions. 
 235. Id. The World Marrow Donor Association (WMDA) fosters international 
collaboration for hematopoietic stem cell transplants worldwide. About WMDA, 
Who We Are, WORLD MARROW DONOR ASSOC., http://www.worldmarrow.org/ (last 
visited May 24, 2013). The WMDA International Standards for Unrelated 
Hematopoietic Stem Cell Donor Registries requires that “donations must be 
voluntary.” WMDA International Standards for Unrelated Hematopoietic Stem 
Cell Donor Registries, WORLD MARROW DONOR ASSOC. 7 (2012), 
http://www.worldmarrow.org/fileadmin/ 
Committees/STDC/20120101-STDC-WMDA_Standards.pdf. The standards 
further state that “[d]onors must not be paid for their donation but may be 
reimbursed for expenses incurred during the donation process.” Id. 
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involved an international donor or international patient.236 
Some worry that compensation for bone marrow donation could 
have a severe impact on both the United States and 
international community if international registries excluded 
the United States where PBSC payments were allowed.237 
These advocates of an altruistic donor system claim that such a 
system is far superior to one motivated by financial incentives 
and that interpreting the current federal law to allow 
compensation of marrow donors “carries serious risks.”238 By 
allowing payment for bone marrow (technically, stem cells) 
extracted by apheresis, patients may not be able to use the 
worldwide search process that is considered imperative to help 
increase access to donors.239 
Those who advocate bone marrow markets argue that 
international organizations have often followed the United 
States’ lead when dealing with novel technological and 
scientific issues.240 In fact, the United States has the largest 
bone marrow registry in the world.241 Advocates of a market-
based system in bone marrow argue that the United States 
should not worry about following others’ leads, but rather be a 
pioneer in allowing compensation for bone marrow.242 
Additionally, it is unlikely that there will be a significant 
change in bone marrow donations just based on the Flynn 
decision. In fact, the plaintiffs in Flynn were not seeking any 
type of monetary compensation for bone marrow. Rather, as 
discussed earlier, MMD was proposing scholarship programs 
that would compensate bone marrow donors with a $3,000 
scholarship.243 
 
 
 
 236. Boo, supra note 234. 
 237. Id. 
 238. Id. 
 239. Leading Global Cell Therapy Organizations Support DOJ Appeal of 
Ruling on Donor Compensation, NAT’L MARROW DONOR PROGRAM (Feb. 2, 2012), 
http://marrow.org/News/News_Releases/2012/Coalition_says_PBSC_donor_compe
nsation_poses_health_risks_to_patients_and_donors.aspx. There is also a concern 
that those wishing to sell their bone marrow are “more likely to withhold medical 
details and information that could harm patients.” Id. Also, there is a concern 
that compensation could deter altruistic donors. Id. 
 240. See Patty B. Wight, Bone Marrow Transplant Donors Compensation Case, 
THE ME. PUB. BROAD. NETWORK (Apr. 24, 2012), http://www.mpbn.net/News/ 
MPBNNews/tabid/1159/ctl/ViewItem/mid/3762/ItemId/21510/Default.aspx. 
 241. Id. 
 242. See id. 
 243. Id.; Flynn v. Holder, 684 F.3d 852, 858 (9th Cir. 2012). 
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VI. A NEW FRONTIER?: COMPENSATION FOR CORD BLOOD 
AFTER FLYNN V. HOLDER 
 
The lack of minority or mixed-race bone marrow, PBSC, or 
cord blood donors is a significant public health problem in the 
United States that has not been addressed adequately. Rather 
than just focusing on bone marrow and PBSC donors, it is 
prudent to focus on increasing cord blood donations as a 
method of overcoming this problem. This Article argues that 
the Ninth Circuit’s ruling in Flynn that compensation for 
PBSCs is acceptable in some circumstances would also allow 
compensation for cord blood. If cord blood compensation is 
allowed and structured properly, the health outcomes of those 
who are unable to find a bone marrow match or cord blood 
match could be significantly improved. 
This Section proceeds as follows. Part A analyzes how 
Flynn leaves open the possibility that cord blood compensation 
is allowed under NOTA. Part B proposes schemes whereby 
public cord blood donations could be increased with prudent 
compensation schemes. 
 
A. Reading Between the Lines: Flynn and Cord Blood 
Compensation 
 
The holding in Flynn applies to cord blood because (1) cord 
blood, unlike bone marrow, is not explicitly mentioned by 
statute or by HHS regulation; (2) the procedure to utilize cord 
blood was not in practice at time of NOTA passage and could 
therefore not have been contemplated by Congress; (3) when 
Congress revisited NOTA and passed later amendments, it 
chose not to modify the statute to explicitly include cord blood; 
and (4) the long-standing view that blood should not be covered 
by NOTA’s prohibitions applies equally to cord blood. 
As discussed in Part II, NOTA makes it a crime for “any 
person to knowingly acquire, receive, or otherwise transfer any 
human organ for valuable consideration for use in human 
transplantation if the transfer affects interstate commerce.”244 
Under NOTA, human organs include “the human . . . kidney, 
liver, heart, lung, pancreas, bone marrow, cornea, eye, bone, 
and skin . . . and any other human organ . . . specified by the 
 
 244. 42 U.S.C. § 274e (2007). 
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Secretary of Health and Human Services by regulation.”245 The 
Secretary of Health and Human Services specified other 
human organs by adding, through regulations, “intestine, 
including the esophagus, stomach, small and/or large intestine, 
or any portion of the gastrointestinal tract.”246 
In Flynn, the Ninth Circuit held that compensation for 
PBSCs extracted through apheresis was not prohibited by 
NOTA.247 The court found that NOTA was constitutional with 
regard to banning compensation for bone marrow extracted via 
aspiration because bone marrow was specifically listed as a 
“human organ” in NOTA.248 In contrast, neither the umbilical 
cord nor umbilical cord blood is mentioned in NOTA. 
Further, the Ninth Circuit held that NOTA contained no 
prohibition against extraction of PBSCs through apheresis 
because this method did not exist when Congress passed 
NOTA.249 The Ninth Circuit went on to say that Congress 
therefore did not intend to address the apheresis method.250 
These findings are equally true about cord blood donation. 
NOTA was approved in 1984,251 and the first cord blood 
transplant did not occur until October 1988.252 Therefore, using 
Flynn’s reasoning, similar to apheresis, Congress could not 
have intended to include cord blood in its prohibition on 
payment for organs. 
When NOTA was amended in 1988253 and 1990, PBSC 
retrieval via apheresis and cord blood donations had begun to 
take place.254 However, the amendments did not mention 
either PBSCs extracted via apheresis nor umbilical cord 
blood.255 The Ninth Circuit held in Flynn that because it was 
 
 245. Id. 
 246. 42 C.F.R. § 121.13 (2007). 
 247. Flynn, 684 F.3d at 865. 
 248. Id. at 859–60. 
 249. Id. at 862. 
 250. Id.; see also supra text accompanying note 220. 
 251. National Organ Transplant Act, Pub. L. 98-507, 98 Stat. 2339 (1984) 
(codified as amended at 42 U.S.C. § 274e (2006)). 
 252. Hal E. Broxmeyer, Cord Blood Transplantation: A Mini Review 
Celebrating the 20th Anniversary of the First Cord Blood Transplant, THE 
HEMATOLOGIST, Jan–Feb. 2009, available at http://www.hematology.org/ 
Publications/Hematologist/2009/2199.aspx. 
 253. Organ Transplant Amendments Act of 1988, Pub. L. 100–607, Tit. IV, 102 
Stat. 3114 (1988) (codified as amended at 42 U.S.C. § 274 (2007)). 
 254. Martin Körbling & Emil J. Freireich, 25 Years of Peripheral Blood Stem 
Cell Transplantation, BLOOD 8, available at http://bloodjournal.hematologyl 
ibrary.org/content/early/2011/04/01/blood-2010-12-322214.full.pdf. 
 255. Organ Transplant Amendment Act Tit. IV, 102 Stat. 3114. 
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not specifically mentioned, PBSCs extracted via apheresis were 
not covered under NOTA’s prohibitions.256 Although the court 
was not asked by the plaintiffs in Flynn to interpret cord blood 
under NOTA, based on the court’s own reasoning it seems 
likely that the court would have ruled the same way—finding 
that it is not covered because it is not mentioned in NOTA or 
its amendments. 
Additionally, the Organ Transplant Amendments Act of 
1988 amended NOTA to add a prohibition on fetal organs but 
did not mention umbilical cords or umbilical cord blood.257 
NOTA specifies organs and does not mention umbilical cords or 
cord blood.258 Although NOTA contains language describing the 
‘human organ’ to include “any subpart thereof and any other 
human organ (or any subpart thereof, including that derived 
from a fetus),”259 the defendant in Flynn unsuccessfully argued 
that PBSCs were a “subpart thereof” of bone marrow and 
therefore compensation for them should not be allowed.260 The 
Ninth Circuit reasoned that this would be too expansive a 
definition and would include blood as well, which is not covered 
by NOTA.261 Even more than PBSCs, cord blood does not fit 
into any of the definitions of any of the organs named in NOTA. 
Peripheral stem cells are a subpart of bone marrow, but the 
Ninth Circuit rejected this interpretation of NOTA because it 
would then also include blood, which is a subpart of each 
organ.262 In contrast, cord blood is not a subpart of any organ. 
Again, the Ninth Circuit’s reasoning about blood is very 
applicable to cord blood. Cord blood is just blood that is derived 
from the umbilical cord.263 If blood is exempted from NOTA, 
cord blood should be as well. 
Some may argue that the umbilical cord is an organ. 
NOTA does not define an organ, but it gives examples of 
organs, which do not include the umbilical cord. In medical 
terminology, an organ is defined as “a differentiated structure 
(as a heart or kidney) consisting of cells and tissues and 
 
 256. Flynn v. Holder, 684 F.3d 852, 865 (9th Cir. 2012). 
 257. Organ Transplant Amendments Act of 1988, Pub. L. 100–607, Tit. IV, 102 
Stat. 3114 (1988) (codified as amended at 42 U.S.C. § 274 (2007)). 
 258. 42 U.S.C. § 274e (2007). 
 259. Id. § 274e(c)(1). 
 260. Flynn, 684 F.3d at 865. 
 261. Id. 
 262. Id. at 863. 
 263. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1. 
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performing some specific function in an organism.”264 The 
umbilical cord is defined not as an organ but as “a cord arising 
from the navel that connects the fetus with the placenta and 
contains the two umbilical arteries and the umbilical vein.”265 
The umbilical cord seems to be more akin to a blood vessel than 
to an organ. Arguably, the umbilical cord could be considered 
an organ because it is a differentiated structure that connects 
the fetus to the pregnant woman. However, its function ceases 
once the newborn is delivered.266 In fact, the cord is clamped 
and in 97 percent of cases, the remaining umbilical cord is 
discarded.267 At this point, it could be argued that the umbilical 
cord is no longer “performing some specific function” in the 
human body, and is no longer even a part of the human body, 
and thus cannot be considered an organ. Unlike a kidney or 
heart that also ceases to perform a specific function once it has 
been removed, the umbilical cord cannot resume its prior 
functioning even if it could be transplanted to another person, 
thus further supporting the argument that it should be not 
classified as an organ. 
Even if one is not persuaded that the umbilical cord is not 
an organ, it is actually not the umbilical cord for which 
compensation would be theoretically given. What is valuable is 
the cord blood, defined as “blood from the umbilical cord of a 
fetus or newborn.”268 In Flynn, the Ninth Circuit rejected the 
Attorney General’s argument that hematopoietic stem cells 
(which are located in the veins) should be treated as “bone 
marrow” because the statute prohibits compensation not only 
for donation of an organ but also any subpart thereof.269 The 
Ninth Circuit reasoned that if the language of the statute were 
permitted to be interpreted this way, then blood would fall 
under the category of “human organ” as red and white blood 
cells that flow in the veins come from the bone marrow, just as 
 
 264. Organ, MERRIAM-WEBSTER, http://www.merriam-webster.com/medical/ 
organ (last visited Nov. 14, 2012). 
 265. Umbilical Cord, MERRIAM-WEBSTER, http://www.merriam-webster.com/ 
medical/umbilical%20cord (last visited Nov. 14, 2012). 
 266. Dr. Allan Bruckheim, Q. What Happens to the Umbilical Cord Inside a 
Mother Once . . ., CHI. TRIB. (Oct. 25, 1994), http://articles.chicagotribune.com/19 
94-10-25/news/9410260009_1_umbilical-cord-uterus-placenta. 
 267. Frequently Asked Questions, SAVE THE CORD FOUND., http://www. 
savethecordfoundation.org/what_faq.php (last visited Mar. 7, 2013). 
 268. Cord Blood, MERRIAM-WEBSTER, http://www.merriam-webster.com/ 
medical/cord%20blood (last visited Nov. 14, 2012). 
 269. Flynn v. Holder, 684 F.3d 852, 863 (9th Cir. 2012). 
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hematopoietic stem cells do.270 It reasoned that once these stem 
cells are in the bloodstream, they are a “subpart” of the blood, 
not the bone marrow.271 The Ninth Circuit then stated that 
“[t]he word ‘subpart’ refers to the organ from which the 
material is taken, not the organ in which it was created.”272 It 
reasoned that the PBSC apheresis method of bone marrow 
transplantation is not the transfer of an organ or a subpart 
thereof.273 Accordingly, the statute does not criminalize the 
compensation of the donor when this method is used.274 This 
reasoning would apply to cord blood as well. The legislative 
history of NOTA notes that the definition of “human organ” 
specifically does not include blood.275 This should be read to 
include cord blood, as cord blood is merely blood that is located 
within the umbilical cord. Since it is arguably more valuable 
due to its stem-cell-rich content, that should be even more 
reason why it would not be included in NOTA’s prohibitions. 
The legislative history of NOTA states that “individuals or 
organizations should not profit by the sale of human organs for 
transplantation. This is not meant to include blood and blood 
derivatives, which can be replenished and whose donation does 
not compromise the health of the donor.”276 There may be a 
concern that cord blood is not replenishable, unlike PBSCs, 
sperm, eggs, or hair. The legislative history of NOTA does note 
that these exceptions to NOTA are for replenishable body 
parts.277 However, a reasonable interpretation of the “which 
can be replenished and whose donation does not compromise 
the health of the donor” language is that the concern over 
bodily material being replenishable is just to ensure that the 
donor is no worse off by having donated that material. Under 
NOTA, it appears unacceptable to allow payment for bodily 
material that, if donated, would put the donor in a worrisome 
 
 270. Id. 
 271. Id. 
 272. Id. 
 273. Id. 
 274. Id. at 865; see also supra note 224 and accompanying text. 
 275. H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.). 
 276. S. REP. NO. 98-382, at 16–17 (1984), reprinted in 1984 U.S.C.C.A.N. 3975, 
3982. 
 277. H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.) (“The term ‘human organ’ 
is not intended to include replenishable tissues such as blood or sperm.”); see also 
J. Brad Reich & Dawn Swink, You Can’t Put the Genie Back in the Bottle: 
Potential Rights and Obligations of Egg Donors in the Cyberprocreation Era, 20 
ALB. L.J. SCI. & TECH. 1, 24 (2010) (noting that NOTA does not prohibit payment 
for human eggs). 
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state of health. The Committee seems concerned that the 
health of an individual is not permanently compromised in 
some way.278 In essence, this concern presupposes an ongoing 
need for similar material from the donor. Obviously, this is not 
the case with a discarded umbilical cord. 
One argument against compensation being allowable 
under NOTA may be that cord blood stem cells are not 
regenerated within the body of the donor. The concern seems to 
be about making the individual “whole” or the same as they 
were before they donated. Therefore, one could argue that this 
resembles an organ for which one cannot be compensated 
under NOTA. However, cord blood is not retrieved from a baby 
directly. There is no need for regeneration, as it is already cut 
from the body of the newborn. If anything, there is more of an 
argument to allow cord blood compensation than any other 
type of blood product because there is no impact on the 
donor.279 NOTA’s legislative history suggests that payment was 
allowed for hair, blood, eggs, and sperm because the human 
body replaces these materials within a certain period of time 
and the individual is not any worse off.280 In contrast, organs 
for which payment is not allowed, such as kidneys, do not 
regenerate. But, cord blood does not even need to be 
replenished, taking it one step further away from the 
underlying health concerns for organs or replenishable bodily 
materials. The reality is that individuals who donate, or even 
are paid for their cord blood, do not have their health 
compromised in any way. 
Further, at the time NOTA was enacted, cord blood 
transplants were not standard practice and cord blood uses 
were just beginning to be explored.281 Therefore, the language 
in the statute or legislative history could not have 
contemplated cord blood. In 1984, it is probable that the only 
bodily materials that could have been used without 
compromising the health of the individual were replenishable 
materials, such as blood, sperm, and eggs.282 That, coupled 
with the exceptions for blood compensation under NOTA, 
makes it more likely that NOTA would be interpreted not to 
 
 278. See H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.). 
 279. Frequently Asked Questions, supra note 267 (noting that “donation of the 
cord blood does not harm the baby or the mother”). 
 280. See H.R. REP. No. 98-1127, at 16. 
 281. See supra notes 251–54 and accompanying text. 
 282. This author contends.  
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cover cord blood.283 
Using Flynn’s reasoning with regard to PBSCs extracted 
through apheresis, this Article contends that cord blood is more 
similar to hair, blood, eggs, sperm, and PBSCs, which are all 
exempted from NOTA’s compensation requirements. Therefore, 
NOTA would arguably allow compensation for cord blood. 
 
B. An Easy Answer? Compensating Cord Blood Donors 
 
If compensation for cord blood is permitted under NOTA, 
there are still several questions to be answered: How should 
donors be compensated? Is compensation alone enough to 
address the public health need for cord blood? Is the current 
collection and banking process sufficient even with 
compensation? The following section of this Article addresses 
these and other questions regarding cord blood compensation. 
 
1. How to Compensate Cord Blood Donors 
 
There are a variety of possible forms that compensation for 
cord blood could take. The most obvious model would be to have 
existing organizations that advocate for more bone marrow and 
PBSC donors, such as MMD, offer financial incentives to 
minority and mixed-race cord blood donors. In Flynn, MMD 
sought to make bone marrow donation more attractive by 
providing compensation to potential bone marrow and PBSC 
donors.284 MMD proposed offering $3,000 awards in the form of 
scholarships, housing allowances, or charitable donations to 
potential donors.285 Flynn allowed MMD to proceed with its 
plans to recruit potential donors of PBSC.286 MMD proposed to 
offer compensation only to minorities and mixed-race 
individuals in the first phase of the program due to the dearth 
of donors in these populations.287 MMD could offer similar 
compensation to ethnic minority or mixed-race pregnant 
women who agree to donate their cord blood to a public bank. 
MMD structured its proposed compensation program to allay 
concern that compensation would change clinical behavior or be 
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subject to manipulation.288 In the case of cord blood, this is not 
a concern. Once the cord is cut from the mother, she and her 
baby are no longer involved in any potential clinical matching 
or anything related to the donation. The cord blood extraction 
occurs after delivery, and the cord blood is sent to a public 
bank. MMD would not need to be involved in matching donors 
and recipients. MMD and similar organizations could facilitate 
the public donation process for pregnant women in addition to 
providing stipends. To receive compensation, pregnant women 
wishing to donate their baby’s cord would need to have the 
requisite medical tests and meet the same standards that all 
donors to public cord banks must meet.289 Unlike in PSBC or 
bone marrow transplants, there are no behavioral questions 
that could be manipulated because of the possibility of 
compensation because the cord is going to be discarded 
anyway.290 
Instead of scholarships as proposed by MMD, cord blood 
donors could receive a stipend towards their medical expenses 
or a savings bond for their child. This may help convince 
women to donate their cord blood as it will benefit their child in 
the future. This could be a true insurance policy, as opposed to 
the fictional insurance policy noted earlier in this Article that 
is marketed by private cord blood banks. 
It may be worthwhile to create a tax credit for those who 
participate in public cord donations. The costs of private cord 
blood banking are considered a medical expense which may be 
deducted from a family’s salary.291 Currently, there is no such 
tax advantage for donating cord blood. Structuring cord blood 
donation to public banks as tax credits could serve as an 
incentive for expectant mothers to donate their valuable cord 
blood. 
Whatever the form, compensation could increase interest 
in cord blood donation. However, compensation alone will likely 
not be the most compelling answer to this public health 
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concern. 
 
2. Need for a Public Health Education Campaign on 
Cord Blood Donation 
 
One of the most effective tools of public health is education. 
The public, and especially pregnant women, needs to be made 
aware of the scientific benefits of cord blood and the ease of 
cord blood donation. The proliferation of private cord blood 
banks that encourage private storage has led to those who are 
aware of the importance of stem cells to privately bank cord 
blood, rather than donate their cord blood to public banks.292 
As opposed to the thousands of dollars spent to store cord 
blood, donation to a public bank is free.293 If more expectant 
mothers, especially those who are carrying mixed-race or 
ethnic minority babies, were made aware of the dire shortage of 
cord blood units by these groups, they would likely be more apt 
to donate.294 Public health education is required so that 
pregnant mothers are told that by donating their baby’s cord 
blood to a public bank, they may be helping people in need of 
potentially life-saving cord blood.295 
Despite the lack of a proven scientific basis for private cord 
blood banking, private cord blood banking seems to be 
flourishing,296 while the growth of a public banking system has 
been painstakingly slow.297 Researchers in this area advocate 
patient education as “the key to shifting the focus to a public 
cord blood banking system.”298 Because private cord blood 
banks have a “significant conflict of interest” in providing 
balanced scientific data about cord blood banking, obstetricians 
should “provide evidence-based information to patients.”299 
Pregnant women should be made aware that public cord blood 
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banking is a better scientific alternative to private cord blood 
storage.300 
Some pregnant women may be concerned about whether 
cord blood donation will harm the baby in any way. Pregnant 
women should be made aware that their babies’ cord blood is 
extracted with no pain to their babies.301 The cord blood, which 
is normally discarded along with the cord, would be a potential 
source of life for those sick individuals who are in need of a 
stem cell transplant. 
One issue that may need to be addressed in a public health 
education campaign is the distrust by many African Americans 
of the public health system in general302 due to the checkered 
history of public health disasters such as the Tuskegee Syphilis 
Study,303 forced sterilizations and Norplant,304 and even more 
recently, the use of stored blood spots for DNA research.305 
Issues of racial distrust must be proactively addressed. 
Literature in the form of “Q and As” addressing these issues 
may be helpful to quell fears of some that their babies’ cord 
blood will be used for purposes other than donation. A 
comprehensive public health education campaign, 
acknowledging this distrust and explaining the benefits of cord 
blood and of public cord blood banking, would likely increase 
donors. 
 
3. Additional Issues to Be Addressed to Bolster Cord 
Blood Donation 
 
Cord blood donation should be encouraged, not made to be 
a chore. Given that the Flynn decision seems to allow 
compensation for cord blood, this compensation could be used 
to incentivize public donations. We would go far in addressing 
the lack of minority and mixed-race bone marrow matches by 
making it seamless and easy for pregnant women to donate 
cord blood. Having pregnant women who are interested in cord 
blood donation jump through hoops to do something 
worthwhile, painless, and easy helps to explain in part why 
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cord blood donations to public banks are so rare. This could be 
changed if pregnant women were offered modest incentives to 
donate their baby’s cord blood. As stated above, this could take 
the form of a minimal credit (such as $100 or $200) towards 
their medical expenses or a savings bond or scholarship for 
their babies to use in the future. 
There is a lack of knowledge among expectant women 
about cord blood donation.306 Many women and health care 
providers are not always aware of the possibility to donate 
their cord blood.307 There are no glossy pamphlets in most 
obstetricians’ offices or hospitals espousing the benefits of cord 
donation to compete with the literature given by the private 
cord blood banks.308 In the last several years, twenty-seven 
states have passed legislation to encourage physicians to 
discuss cord blood donation and banking with pregnant 
women.309 However, the reality is that public cord blood banks 
do not operate all over the United States, while private cord 
banks do.310 Another issue is that the process to donate cord 
blood is often complicated.311 It is not the routine practice 
currently to expect that most mothers will donate their babies’ 
cord blood. Unless a woman happens to be delivering in one of 
the very few hospitals that is set up for public donations, a 
woman who does decide to donate must prepare far in 
advance.312 She must request a packet of materials from public 
banks and these must be completed before labor and 
delivery.313 This complicated and sometimes confusing process 
for an expectant mother is an additional hassle that prevents 
more women from donating cord blood.314 
ACOG should consider making cord blood donation a 
standard practice in each delivery. ACOG releases practice 
guidelines for each aspect of labor and delivery and has 
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previously considered the issue of cord blood banking.315 
However, ACOG should be encouraged to go further. ACOG has 
the power and expertise to deem that unless a pregnant woman 
decides to opt out of donating her cord blood, the standard 
practice will be to presume donation316 and give compensation 
to cover the costs of collection. This would have an incredible 
effect of vastly increasing the public cord blood supply in the 
United States. Rather than the arduous opt-in procedure that 
currently exists and dissuades all but the most committed 
altruistic cord blood donors, an opt-out policy would increase 
the number of cord blood donations. Additionally, this would 
not prevent anyone who wishes to privately bank their baby’s 
cord blood from doing do. Individuals may still choose to 
privately donate instead.  
Currently, almost 97 percent of cord blood is discarded as 
medical waste.317 Therefore, the routine practice is to discard 
the umbilical cord. However, if ACOG advocates a change in 
the routine practice, the percentage of donated cord blood 
would rise dramatically. The revised routine practice could be 
to preserve the cord blood, while still allowing the patient the 
choice of public donation or private banking (if, for example, 
there is a family member with an illness that could be helped 
by cord blood). Because extracting the cord blood from the cut 
umbilical cord takes additional time,318 there could be 
reimbursement or compensation incentives put into place so 
that physicians and nurses would be paid for this extraction. 
All of these suggestions would significantly increase the 
potential for matching cord blood for ethnic minorities and 
mixed-race individuals. By simplifying the process to donate 
cord blood and making it the routine practice, the number of 
donations would increase, which would increase minority 
donations available for transplants.319 
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Existing public health screening models could be modified 
to accommodate cord blood donation. For example, unless a 
mother decides to proactively opt-out of testing, in every state, 
every newborn is subjected to a heel prick so that the baby’s 
blood may be screened for a slew of metabolic and other 
diseases.320 This opt-out model of newborn screening could be 
used to formulate an opt-out model of cord blood donation. As 
of now, women and families who wish to donate cord blood 
must proactively seek out ways to donate to a public bank.321 
 
CONCLUSION 
 
Although this Article advocates for an increased emphasis 
for public banking, it is important to acknowledge the 
downsides to donating to a public bank. One of the most 
obvious downsides is that once cord blood is donated to a public 
bank, public banks own the donated cord blood.322 Thus, that 
cord blood may not be available for one’s own family member 
should a need arise.323 If a family member or a sibling needs 
the cord blood in the future, it will not be readily available.324 
Although it is unlikely that one’s own cord blood would be 
useful to that individual if he or she suffers from a disease,325 
the use of cord blood from one’s immediate family doubles the 
chance of a successful transplant.326 Theoretically, minorities 
and mixed-race individuals may be more worried about the 
lack of stem cell matches and may wish to store their baby’s 
cord blood at a private facility for future use.327 However, 
 
2013). 
 320. Newborn Screening Tests, MEDLINEPLUS, http://www.nlm.nih.gov/ 
medlineplus/ency/article/007257.htm (last visited Mar. 28, 2013). 
 321. Frequently Asked Questions, supra note 267. Public cord blood banks 
generally do not charge to harvest the cord blood. Id. However, physicians may 
choose to charge a collection fee not covered by insurance. Cord Blood Banking 
Pros and Cons, supra note 109. Some physicians have waived any collection fee 
for public bank donations. Id. However, if cord blood donation becomes more 
prevalent, this could change. Harvesting cord blood from the cut cord does take 
away time from staff to do other things, and physicians or hospitals could charge 
to harvest the cord blood. One of the ways compensation could be used would be to 
pay hospitals and physicians a fee to cover the cost of this extra time. 
 322. Cord Blood Banking Pros and Cons, supra note 109. 
 323. Id. 
 324. Id. 
 325. Id.; Moninger, supra note 48. 
 326. Cord Blood, WOMEN’S HEALTH OF MANSFIELD PA., http://www. 
womenshealthofmansfield.com/cord-blood/ (last visited Feb. 10, 2013). 
 327. See Cord Blood Banking Pros and Cons, supra note 109. 
2013] CUTTING THE CORD 983 
currently, there are a very small percentage of minorities who 
store their babies’ cord blood.328  
This Article does not propose eliminating private banking. 
If this concern is worrisome for individuals, they may still 
choose to privately bank their babies’ cord blood. This Article 
proposes methods, including compensation, to encourage cord 
blood banking in general, particularly to the vast majority of 
the public that allows their babies’ cord blood to be discarded. 
Because Flynn seems to allow payment for cord blood, public 
health officials, professional organizations, and nonprofits 
should work together to devise compensation schemes that 
would increase the public cord blood supply in the United 
States. 
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